<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Med Genet</journal-id><journal-title>BMC Medical Genetics</journal-title><issn pub-type="epub">1471-2350</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1471-2350-8-S1-S10</article-id><article-id pub-id-type="doi">10.1186/1471-2350-8-S1-S10</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>A genome-wide association for kidney function and endocrine-related traits in the NHLBI's Framingham Heart Study</article-title></title-group><contrib-group><contrib id="A1" contrib-type="author"><name><surname>Hwang</surname><given-names>Shih-Jen</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>hwangs2@nhlbi.nih.gov</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Yang</surname><given-names>Qiong</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>qyang@bu.edu</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Meigs</surname><given-names>James B</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>jmeigs@partner.org</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Pearce</surname><given-names>Elizabeth N</given-names></name><xref ref-type="aff" rid="I4">4</xref><email>Elizabeth.pearce@bmc.org</email></contrib><contrib id="A5" corresp="yes" contrib-type="author"><name><surname>Fox</surname><given-names>Caroline S</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I5">5</xref><email>foxca@nhlbi.nih.gov</email></contrib></contrib-group><aff id="I1"><label>1</label>National Heart Lung and Blood Institutes, Bethesda, MD, USA</aff><aff id="I2"><label>2</label>Massachusetts General Hospital and Harvard Medical School , Boston, MA, USA</aff><aff id="I3"><label>3</label>Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA</aff><aff id="I4"><label>4</label>Boston University School of Medicine, Boston, MA, USA</aff><aff id="I5"><label>5</label>Department of Endocrinology, Diabetes, and Hypertension, the Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA</aff><pub-date pub-type="collection"><year>2007</year></pub-date><pub-date pub-type="epub"><day>19</day><month>9</month><year>2007</year></pub-date><volume>8</volume><issue>Suppl 1</issue><supplement><named-content content-type="supplement-title">The Framingham Heart Study 100,000 single nucleotide polymorphisms resource</named-content><named-content content-type="supplement-editor">Emelia J Benjamin, Caroline S Fox, Daniel J Gottlieb, Cashell E Jaquish, Daniel Levy, James B Meigs, Christopher Newton-Cheh, Christopher J O'Donnell and Ramachandran S Vasan</named-content><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/content/pdf/1471-2350-8-S1-info.pdf">http://www.biomedcentral.com/content/pdf/1471-2350-8-S1-info.pdf</ext-link></supplement><fpage>S10</fpage><lpage>S10</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2350/8/S1/S10"/><permissions><copyright-statement>Copyright &#x000a9; 2007 Hwang et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2007</copyright-year><copyright-holder>Hwang et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an open access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> Hwang Shih-Jen hwangs2@nhlbi.nih.gov </dc:author><dc:title> A genome-wide association for kidney function and endocrine-related traits in the NHLBI's Framingham Heart Study </dc:title><dc:date>2007</dc:date><dcterms:bibliographicCitation>BMC Medical Genetics 8(Suppl 1): S10-. (2007)</dcterms:bibliographicCitation><dc:identifier type="sici">1471-2350(2007)8:Suppl 1&#x0003c;S10&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1471-2350</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>Glomerular filtration rate (GFR) and urinary albumin excretion (UAE) are markers of kidney function that are known to be heritable. Many endocrine conditions have strong familial components. We tested for association between the Affymetrix GeneChip Human Mapping 100K single nucleotide polymorphism (SNP) set and measures of kidney function and endocrine traits.</p></sec><sec sec-type="methods"><title>Methods</title><p>Genotype information on the Affymetrix GeneChip Human Mapping 100K SNP set was available on 1345 participants. Serum creatinine and cystatin-C (cysC; n = 981) were measured at the seventh examination cycle (1998&#x02013;2001); GFR (n = 1010) was estimated via the Modification of Diet in Renal Disease (MDRD) equation; UAE was measured on spot urine samples during the sixth examination cycle (1995&#x02013;1998) and was indexed to urinary creatinine (n = 822). Thyroid stimulating hormone (TSH) was measured at the third and fourth examination cycles (1981&#x02013;1984; 1984&#x02013;1987) and mean value of the measurements were used (n = 810). Age-sex-adjusted and multivariable-adjusted residuals for these measurements were used in association with genotype data using generalized estimating equations (GEE) and family-based association tests (FBAT) models. We presented the results for association tests using additive allele model. We evaluated associations with 70,987 SNPs on autosomes with minor allele frequencies of at least 0.10, Hardy-Weinberg Equilibrium p-value &#x02265; 0.001, and call rates of at least 80%.</p></sec><sec><title>Results</title><p>The top SNPs associated with these traits using the GEE method were rs2839235 with GFR (p-value 1.6*10<sup>-05</sup>), rs1158167 with cysC (p-value 8.5*10<sup>-09</sup>), rs1712790 with UAE (p-value 1.9*10<sup>-06</sup>), and rs6977660 with TSH (p-value 3.7*10<sup>-06</sup>), respectively. The top SNPs associated with these traits using the FBAT method were rs6434804 with GFR(p-value 2.4*10<sup>-5</sup>), rs563754 with cysC (p-value 4.7*10<sup>-5</sup>), rs1243400 with UAE (p-value 4.8*10<sup>-6</sup>), and rs4128956 with TSH (p-value 3.6*10<sup>-5</sup>), respectively. Detailed association test results can be found at <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?id=phs000007"/>. Four SNPs in or near the <italic>CST</italic>3 gene were highly associated with cysC levels (p-value 8.5*10<sup>-09 </sup>to 0.007).</p></sec><sec><title>Conclusion</title><p>Kidney function traits and TSH are associated with SNPs on the Affymetrix GeneChip Human Mapping 100K SNP set. These data will serve as a valuable resource for replication as more SNPs associated with kidney function and endocrine traits are identified.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>Kidney disease affects 19 million adults in the United States [<xref ref-type="bibr" rid="B1">1</xref>]. Chronic kidney disease (CKD) is associated with cardiovascular disease [<xref ref-type="bibr" rid="B2">2</xref>-<xref ref-type="bibr" rid="B4">4</xref>], stroke [<xref ref-type="bibr" rid="B5">5</xref>], peripheral arterial disease [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref>], and all-cause mortality [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>]. CVD risk factors are associated with the development of kidney disease [<xref ref-type="bibr" rid="B9">9</xref>], and the prevalence of traditional and novel CVD risk factors is elevated among those with kidney disease [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B10">10</xref>]. Urinary albumin excretion (UAE) is an early marker of kidney function that predicts CKD progression [<xref ref-type="bibr" rid="B11">11</xref>-<xref ref-type="bibr" rid="B14">14</xref>]. While glomerular filtration rate (GFR) and UAE are both measurements for kidney function, they represent different phenotypes and identify different subsets of at-risk individuals [<xref ref-type="bibr" rid="B15">15</xref>].</p><p>Genetic factors play a role in the progression of renal disease. Familial aggregation of end-stage renal disease has been identified [<xref ref-type="bibr" rid="B16">16</xref>]. Linkage analyses of kidney function have been conducted [<xref ref-type="bibr" rid="B17">17</xref>-<xref ref-type="bibr" rid="B21">21</xref>], and novel loci have been mapped to chromosomes 1 [<xref ref-type="bibr" rid="B18">18</xref>], 2 [<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B22">22</xref>], 3 [<xref ref-type="bibr" rid="B17">17</xref>], 7 [<xref ref-type="bibr" rid="B22">22</xref>], 10 [<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B22">22</xref>], and 18 [<xref ref-type="bibr" rid="B22">22</xref>]. In the Framingham Heart Study, we have shown that kidney function is heritable [<xref ref-type="bibr" rid="B23">23</xref>], suggesting a role for genetic mechanisms in its etiology. Results of the linkage study from the Framingham Heart Study suggested linkage between kidney disease and a locus on chromosome 4 with a LOD score of 2.2 [<xref ref-type="bibr" rid="B23">23</xref>]. Familial clustering of UAE has been observed in siblings of subjects with diabetes [<xref ref-type="bibr" rid="B24">24</xref>], and UAE has been shown to be heritable among the offspring of diabetic subjects [<xref ref-type="bibr" rid="B25">25</xref>]. Genome-wide linkage analyses have mapped novel loci to chromosomes 12 [<xref ref-type="bibr" rid="B26">26</xref>] and 19 [<xref ref-type="bibr" rid="B26">26</xref>] among families enriched for hypertension. Among families with more severe forms of nephropathy, suggestive evidence for linkage has been found on chromosome 10p [<xref ref-type="bibr" rid="B27">27</xref>] and 9q31&#x02013;32 [<xref ref-type="bibr" rid="B28">28</xref>]. In the Framingham Heart Study, we observed a LOD score of 2.2 for UAE on chromosome 8 [<xref ref-type="bibr" rid="B29">29</xref>].</p><p>Thyroid disease, including Hashimoto's thyroiditis and Graves' disease, has a known familial component [<xref ref-type="bibr" rid="B30">30</xref>], and the same genes may underlie both conditions [<xref ref-type="bibr" rid="B31">31</xref>]. Measures of thyroid function have been shown to be heritable [<xref ref-type="bibr" rid="B32">32</xref>-<xref ref-type="bibr" rid="B34">34</xref>], and linkage has been reported to chromosome 18 for autoimmune thyroid disease in at least 2 studies [<xref ref-type="bibr" rid="B35">35</xref>,<xref ref-type="bibr" rid="B36">36</xref>].</p><p>As part of the Framingham Heart Study 100K Project, we sought to test the relation of multiple kidney and endocrine traits to 70,987 SNPs. In this manuscript, we focus the results of association studies for GFR, UAE, cysC, and thyroid stimulating hormone (TSH), a sensitive measure of thyroid function.</p></sec><sec sec-type="methods"><title>Methods</title><p>Overall, 1345 participants were genotyped for the Affymetrix GeneChip Human Mapping 100K SNP set. For this manuscript, we focused on GFR from examination 7, UAE from examination 6, serum cysC from examination 7, and mean TSH from examinations 3 and 4. Phenotypes were available in 1010 participants for GFR at exam cycle 7, 822 participants for UAE at exam cycle 6, 981 participants for cysC at exam cycle 7, and 810 participants for mean TSH at exam cycles 3 and 4. Details about the selection process and genotyping are provided in the Overview [<xref ref-type="bibr" rid="B37">37</xref>]. Age-sex- and multivariable-adjusted residuals were generated; we present here only the results for multivariable-adjusted traits (all available results can be found in the website <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?id=phs000007"/>). We evaluated associations with 70,987 SNPs on autosomes with minor allele frequencies of at least 0.10, HWE p-value &#x02265; 0.001, and genotypic call rates of at least 80%.</p><sec><title>Phenotype assessment</title><p>Serum creatinine was measured using the modified Jaffe method at exams 2 (1978&#x02013;1981), 5 (1991&#x02013;1995), 6 (1995&#x02013;1998), and 7 (1998&#x02013;2001), and glomerular filtration rate (GFR) was estimated using the simplified Modification of Diet in Renal Disease Study equation [<xref ref-type="bibr" rid="B38">38</xref>,<xref ref-type="bibr" rid="B39">39</xref>]. CKD was defined based on the National Kidney Foundation Kidney Disease Outcome Quality Initiative working group, and modified slightly as previously described [<xref ref-type="bibr" rid="B9">9</xref>]. Urinary albumin concentration (UAE) was measured by immuno-turbidmetry (Tina-quant Albumin assay; Roche Diagnostics, Indianapolis, IN) during the sixth examination cycle (1995&#x02013;1998). Urinary albumin was indexed to urinary creatinine (as the urine albumin/creatinine ratio, UACR) in order to account for differences in urine concentration. UACR is a validated and reliable single-sample measure of urinary albumin excretion and is highly correlated with albumin excretion rates assessed by 24-h urine collection [<xref ref-type="bibr" rid="B40">40</xref>,<xref ref-type="bibr" rid="B41">41</xref>]. Cystatin-C (cysC) was measured using particle enhanced immunonephelometry (Dade Behring BN 100 nephelometer; Dade Behring &#x02013; Cystatin C reagent) with an inter-assay and intra-assay coefficient of variation of 3.3 and 2.4%, respectively. We have previously published correlates of CKD in the Framingham Heart Study, including hypertension, diabetes, smoking, obesity, and low HDL cholesterol [<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B42">42</xref>].</p><p>TSH was measured using a chemoluminescence assay (London Diagnostics, Eden Prairie, Minn) with a lower limit of detection of 0.01 mU/L. Luteinizing hormone (LH), follicle stimulating hormone (FSH), and dehydroepiandrosterone sulfate (DHEAS) were measured as previously described [<xref ref-type="bibr" rid="B43">43</xref>,<xref ref-type="bibr" rid="B44">44</xref>]. Briefly, DHEAS concentrations were measured on serum samples via radioimmunoassay (Diagnostic Products Corp, CA). Calcium and phosphorous were measured at the second examination cycle using a standard colorimetric method (Roche Diagnostics, Alameda, CA), and uric acid was measured at the second examination cycle using an autoanalyzer with a phosphotungstic acid reagent.</p></sec><sec><title>Genotyping</title><p>Genotyping was performed using the 100K Affymetrix GeneChip. Please see the Overview [<xref ref-type="bibr" rid="B37">37</xref>] for details.</p></sec><sec><title>Statistical methods</title><p>Phenotypes used for the analysis were created by generating normalized residuals. We generated both age-sex adjusted and multivariable adjusted residuals for each trait. Table <xref ref-type="table" rid="T1">1</xref> shows the covariates included in the multivariable adjustment; all data in this manuscript represents the multivariable-adjusted traits. All association analyses were performed using the generalized estimating equations or family based association tests; details are provided in the Overview [<xref ref-type="bibr" rid="B37">37</xref>]. Methods to verify family structure, generate identity-by-descent for these 1345 participants with genotype information as well as the markers used for linkage analysis, is detailed in the Overview [<xref ref-type="bibr" rid="B37">37</xref>]. To assess the clustering of significance between each SNP and phenotypes that were repeatedly measured in several examination cycles (see the third table in this article), we generated the geometric mean of p-values for SNPs that fit the following criteria: at least 4 out of 6 p-values of &#x0003c;0.01 in GEE or FBAT analyses for 6 GFR traits (change in serum creatinine from exam 2 to 7; GFR at exam 2; GFR at exam 5; GFR at exam 6; GFR at exam 7; mean GFR exams 2, 5, 6, 7); one out of two UACR traits (UACR; UACR in a sample enriched for hypertension); three out of three of TSH traits (TSH at exam 3; TSH at exam 4; mean TSH at exams 3 and 4). Among the GFR traits, Pearson correlation coefficients ranged from 0.18 (p &#x0003c; 0.001) between GFR at exam 2 and exam 7, to 0.77 (p &#x0003c; 0.001) for the mean of GFR at exams 2, 5, 6, and 7 and GFR at exam 7. Linkage analysis was performed using the variance components methods on a subset of 100K markers and Marshfield short-tandem repeats; please see the Overview [<xref ref-type="bibr" rid="B37">37</xref>] for more details. Partial R<sup>2</sup>, the adjusted percentage of the phenotype variation explained by the genotype variation, was estimated by subtracting the adjusted R<sup>2 </sup>value for a model that excludes the genotype from the R<sup>2 </sup>value for a model that includes the genotype.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Traits names, Framingham Heart Study examination cycle, and multivariable adjustments</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left">Trait</td><td align="center">Sample size</td><td align="center" colspan="2">Exam cycle/s</td><td></td></tr></thead><tbody><tr><td></td><td></td><td align="center">Offspring</td><td align="center">Original Cohort</td><td align="center">Adjustment<sup>&#x02020;</sup></td></tr><tr><td colspan="5"><hr></hr></td></tr><tr><td align="left">Serum Creatinine</td><td align="center">840&#x02013;1010</td><td align="center">2, 5, 6, 7</td><td align="center">0</td><td align="left">Age and sex; multivariable*</td></tr><tr><td align="left">Change in serum creatinine</td><td align="center">854</td><td align="center">2, 7</td><td align="center">0</td><td align="left">Age and sex; multivariable*</td></tr><tr><td align="left">Glomerular Filtration Rate (GFR)</td><td align="center">840&#x02013;1010</td><td align="center">2, 5, 6, 7</td><td align="center">0</td><td align="left">Age and sex; multivariable*</td></tr><tr><td align="left">Chronic Kidney Disease</td><td align="center">1010</td><td align="center">7</td><td align="center">0</td><td align="left">Age and sex; multivariable*</td></tr><tr><td align="left">Cystatin C</td><td align="center">981</td><td align="center">7</td><td align="center">0</td><td align="left">Age and sex; multivariable*</td></tr><tr><td align="left">Uric acid</td><td align="center">912&#x02013;1031</td><td align="center">1, 2</td><td align="center">0</td><td align="left">Age and sex; multivariable*</td></tr><tr><td align="left">Urinary Albumin Excretion</td><td align="center">822</td><td align="center">6</td><td align="center">0</td><td align="left">Age and sex; multivariable*</td></tr><tr><td align="left">Urinary Albumin Excretion &#x02265; 30 mg/g; Hypertension-enriched sample</td><td align="center">532</td><td align="center">6</td><td align="center">0</td><td align="left">Age and sex; multivariable*</td></tr><tr><td align="left">Serum Calcium</td><td align="center">906</td><td align="center">2</td><td align="center">0</td><td align="left">Age and sex; age, sex, serum creatinine</td></tr><tr><td align="left">Serum Phosphorus</td><td align="center">911</td><td align="center">2</td><td align="center">0</td><td align="left">Age and sex; age, sex, and serum creatinine</td></tr><tr><td align="left">Thyroid stimulation hormone (TSH)</td><td align="center">883</td><td align="center">3</td><td align="center">0</td><td align="left">Age and sex; age, sex, body mass index, smoking, menopausal status, thyroid hormone use</td></tr><tr><td align="left">Mean of TSH exam 3 &#x00026; 4</td><td align="center">810</td><td align="center">3, 4</td><td align="center">0</td><td align="left">Age and sex; age, sex, body mass index, smoking, menopausal status, thyroid hormone use</td></tr><tr><td align="left">Luteinizing hormone (LH) **</td><td align="center">508</td><td align="center">3</td><td align="center">0</td><td align="left">Age and multivariable***</td></tr><tr><td align="left">Follicle stimulating hormone (FSH)**</td><td align="center">509</td><td align="center">3</td><td align="center">0</td><td align="left">Age and multivariable***</td></tr><tr><td align="left">Dehydroepiandrosterone sulfate (DHEAS)</td><td align="center">850</td><td align="center">3</td><td align="center">0</td><td align="left">Age and sex; multivariable***</td></tr></tbody></table><table-wrap-foot><p>*Multivariable adjustment include age, sex, systolic blood pressure, hypertension treatment, HDL-cholesterol, smoking, diabetes, body mass index</p><p>**Men and post-menopausal women only with natural menopause not using hormone replacement treatment or oral contraceptive pills</p><p>*** Age, diabetes mellitus, impaired fasting glucose, smoking, systolic blood pressure, diastolic blood pressure, body-mass index, hypertension treatment, prevalent cardiovascular disease, total cholesterol/HDL ratio and alcohol intake</p></table-wrap-foot></table-wrap></sec></sec><sec><title>Results</title><p>A description of all traits and phenotypes, including relevant examination cycles and multivariable-adjustments, is presented in Table <xref ref-type="table" rid="T1">1</xref>. The median eGFR among individuals with CKD in our sample is 53.7 ml/min/1.73 m<sup>2</sup>. Table <xref ref-type="table" rid="T2">2a</xref> presents the top 25 SNPs with the lowest p-values obtained via GEE for GFR, cysC, UAE, and mean TSH; additional results can be found on the National Center for Biotechnology Information website <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?id=phs000007"/>. The top SNP associated with GFR, cysC, and UAE were rs2829235 (p-value 1.6*10<sup>-05</sup>), rs1158167 (p-value 8.5*10<sup>-09</sup>) near the cysC precursor gene family (<italic>CST</italic>3, <italic>CST</italic>4, <italic>CST</italic>9), and rs1712790 (p-value 1.9*10<sup>-06</sup>), respectively (Table <xref ref-type="table" rid="T2">2a</xref>). The top SNP to be associated with mean TSH was rs6977660 (p-value 3.7*10<sup>-06</sup>). Three SNPs were not shown on Table <xref ref-type="table" rid="T2">2a</xref> due to the linkage disequilibrium (LD) (r<sup>2 </sup>&#x0003e; 0.8) with the other top SNPs. These three SNPs were significantly associated with UAE at exam 6: rs9305355 (p-value 2.1*10<sup>-5</sup>) in LD with rs9305354, rs725304 (p-value 2.5*10<sup>-5</sup>) in LD with rs723464, and rs725307 (p-value 3.2 *10<sup>-5</sup>) in LD with rs723464. Table <xref ref-type="table" rid="T2">2b</xref> presents the top SNPs based on the FBAT procedure. One SNP, rs10511594 (p = 9.0*10<sup>-5</sup>) was in LD (r<sup>2 </sup>&#x0003e; 0.8) with rs7865184 (p = 4.0*10<sup>-5</sup>) for mean TSH.</p><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Most significant results for GFR (examination 7), UAE (examination 6), cysC (examination 7), and mean TSH (examinations 3 and 4) by GEE (2a), FBAT (2b) and linkage (2c) analyses</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left" colspan="7"><bold>2a. </bold>Top 25 SNPs for association with GFR (examination 7), UAE (examination 6), cysC (examination 7), and mean TSH (examinations 3 and 4) based on the lowest p value of the GEE test. Corresponding phenotype names on the web are GFRMV7 (GFR), UAELNMV6 (UAE), CYSCMV7 (CysC), and TSHMEAN34MV (TSH)</td></tr></thead><tbody><tr><td align="left"><bold>TRAIT</bold></td><td align="left"><bold>SNP</bold></td><td align="left"><bold>Physical Location (Mb)</bold></td><td align="left"><bold>Chromosome</bold></td><td align="left"><bold>P value &#x02013; FBAT</bold></td><td align="left"><bold>P value &#x02013; GEE</bold></td><td align="left"><bold>GENE</bold></td></tr><tr><td colspan="7"><hr></hr></td></tr><tr><td align="left">CysC</td><td align="left">rs1158167</td><td align="left">23,526,189</td><td align="left">20</td><td align="left">0.006</td><td align="left">8.5*10<sup>-09</sup></td><td align="left"><italic>CST9L|CST9|CST3</italic></td></tr><tr><td align="left">UAE</td><td align="left">rs1712790</td><td align="left">114,126,679</td><td align="left">11</td><td align="left">0.014</td><td align="left">1.9*10<sup>-06</sup></td><td align="left"><italic>FAM55B</italic></td></tr><tr><td align="left">TSH</td><td align="left">rs6977660</td><td align="left">19,578,720</td><td align="left">7</td><td align="left">0.010</td><td align="left">3.7*10<sup>-06</sup></td><td></td></tr><tr><td align="left">TSH</td><td align="left">rs9322817</td><td align="left">105,338,926</td><td align="left">6</td><td align="left">0.502</td><td align="left">6.5*10<sup>-06</sup></td><td align="left"><italic>HACE1</italic></td></tr><tr><td align="left">TSH</td><td align="left">rs10499559</td><td align="left">21,882,699</td><td align="left">7</td><td align="left">0.068</td><td align="left">8.3*10<sup>-06</sup></td><td align="left"><italic>RAPGEF5</italic></td></tr><tr><td align="left">UAE</td><td align="left">rs9305354</td><td align="left">28,397,067</td><td align="left">21</td><td align="left">0.013</td><td align="left">8.4*10<sup>-06</sup></td><td></td></tr><tr><td align="left">CysC</td><td align="left">rs2145231</td><td align="left">23,573,547</td><td align="left">20</td><td align="left">0.011</td><td align="left">1.1*10<sup>-05</sup></td><td align="left"><italic>CST9|CST3|CST4</italic></td></tr><tr><td align="left">UAE</td><td align="left">rs723464</td><td align="left">133,940,196</td><td align="left">4</td><td align="left">0.000</td><td align="left">1.1*10<sup>-05</sup></td><td></td></tr><tr><td align="left">UAE</td><td align="left">rs2113379</td><td align="left">207,177,180</td><td align="left">2</td><td align="left">0.003</td><td align="left">1.4*10<sup>-05</sup></td><td align="left"><italic>ADAM23</italic></td></tr><tr><td align="left">GFR</td><td align="left">rs2839235</td><td align="left">46,625,020</td><td align="left">21</td><td align="left">0.055</td><td align="left">1.6*10<sup>-05</sup></td><td align="left"><italic>PCNT2</italic></td></tr><tr><td align="left">TSH</td><td align="left">rs10493147</td><td align="left">129,095,104</td><td align="left">4</td><td align="left">0.040</td><td align="left">2.1*10<sup>-05</sup></td><td align="left"><italic>HSPA4L</italic></td></tr><tr><td align="left">TSH</td><td align="left">rs784490</td><td align="left">39,148,534</td><td align="left">3</td><td align="left">0.005</td><td align="left">2.8*10<sup>-05</sup></td><td align="left"><italic>TTC21A</italic></td></tr><tr><td align="left">UAE</td><td align="left">rs278021</td><td align="left">6,698,929</td><td align="left">1</td><td align="left">0.958</td><td align="left">2.9*10<sup>-05</sup></td><td align="left"><italic>DNAJC11</italic></td></tr><tr><td align="left">UAE</td><td align="left">rs1856190</td><td align="left">33,598,615</td><td align="left">9</td><td align="left">0.127</td><td align="left">3.0*10<sup>-05</sup></td><td></td></tr><tr><td align="left">UAE</td><td align="left">rs10485409</td><td align="left">91,562,132</td><td align="left">6</td><td align="left">0.147</td><td align="left">3.1*10<sup>-05</sup></td><td></td></tr><tr><td align="left">UAE</td><td align="left">rs2785980</td><td align="left">216,088,914</td><td align="left">1</td><td align="left">4.8*10<sup>-04</sup></td><td align="left">3.7*10<sup>-05</sup></td><td></td></tr><tr><td align="left">UAE</td><td align="left">rs837678</td><td align="left">191,168,583</td><td align="left">3</td><td align="left">0.012</td><td align="left">3.8*10<sup>-05</sup></td><td align="left"><italic>LEPREL1</italic></td></tr><tr><td align="left">GFR</td><td align="left">rs3095160</td><td align="left">49,844,269</td><td align="left">13</td><td align="left">0.002</td><td align="left">3.8*10<sup>-05</sup></td><td></td></tr><tr><td align="left">UAE</td><td align="left">rs2761171</td><td align="left">99,278,898</td><td align="left">13</td><td align="left">0.078</td><td align="left">4.1*10<sup>-05</sup></td><td align="left"><italic>CLYBL</italic></td></tr><tr><td align="left">GFR</td><td align="left">rs10507344</td><td align="left">24,623,069</td><td align="left">13</td><td align="left">0.017</td><td align="left">4.1*10<sup>-05</sup></td><td align="left"><italic>PABPC3</italic></td></tr><tr><td align="left">GFR</td><td align="left">rs890945</td><td align="left">157,924,801</td><td align="left">5</td><td align="left">0.036</td><td align="left">4.7*10<sup>-05</sup></td><td></td></tr><tr><td align="left">UAE</td><td align="left">rs10502192</td><td align="left">114,127,562</td><td align="left">11</td><td align="left">0.051</td><td align="left">4.9*10<sup>-05</sup></td><td align="left"><italic>FAM55B</italic></td></tr><tr><td align="left">GFR</td><td align="left">rs10489639</td><td align="left">157,492,600</td><td align="left">1</td><td align="left">0.194</td><td align="left">4.9*10<sup>-05</sup></td><td align="left"><italic>CD48</italic></td></tr><tr><td align="left">TSH</td><td align="left">rs9308765</td><td align="left">118,759,439</td><td align="left">2</td><td align="left">0.353</td><td align="left">5.1*10<sup>-05</sup></td><td></td></tr><tr><td align="left">TSH</td><td align="left">rs3908399</td><td align="left">12,849,275</td><td align="left">20</td><td align="left">8.0*10<sup>-04</sup></td><td align="left">5.2*10<sup>-05</sup></td><td></td></tr><tr><td colspan="7"><hr></hr></td></tr><tr><td align="left" colspan="7"><bold>2b. </bold>Top 25 SNPs for association with GFR (examination 7), UAE (examination 6), cysC (examination 7), and mean TSH (examinations 3 and 4) based on the lowest p-value of the FBAT test. Corresponding phenotype names on the web are GFRMV7 (GFR), UAELNMV6 (UAE), CYSCMV7 (CysC), and TSHMEAN34MV (TSH)</td></tr><tr><td colspan="7"><hr></hr></td></tr><tr><td align="left"><bold>TRAIT</bold></td><td align="left"><bold>SNP</bold></td><td align="left"><bold>Physical Location (Mb)</bold></td><td align="left"><bold>Chromosome</bold></td><td align="left"><bold>P value - FBAT</bold></td><td align="left"><bold>P value - GEE</bold></td><td align="left"><bold>GENE</bold></td></tr><tr><td colspan="7"><hr></hr></td></tr><tr><td align="left">GEE</td><td align="left">GENE</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">UAE</td><td align="left">rs1243400</td><td align="left">9,016,664</td><td align="left">10</td><td align="left">4.8*10<sup>-06</sup></td><td align="left">0.036</td><td></td></tr><tr><td align="left">UAE</td><td align="left">rs827640</td><td align="left">9,028,017</td><td align="left">10</td><td align="left">1.5*10<sup>-05</sup></td><td align="left">0.047</td><td></td></tr><tr><td align="left">UAE</td><td align="left">rs7315682</td><td align="left">32,577,224</td><td align="left">12</td><td align="left">2.1*10<sup>-05</sup></td><td align="left">0.28</td><td align="left"><italic>FGD4</italic></td></tr><tr><td align="left">GFR</td><td align="left">rs6434804</td><td align="left">196,589,899</td><td align="left">2</td><td align="left">2.4*10<sup>-05</sup></td><td align="left">0.003</td><td align="left"><italic>DNAH7</italic></td></tr><tr><td align="left">UAE</td><td align="left">rs1543468</td><td align="left">230,655,160</td><td align="left">1</td><td align="left">2.5*10<sup>-05</sup></td><td align="left">0.253</td><td align="left"><italic>SLC35F3</italic></td></tr><tr><td align="left">UAE</td><td align="left">rs723464</td><td align="left">133,940,196</td><td align="left">4</td><td align="left">2.7*10<sup>-05</sup></td><td align="left">1.0*10<sup>-05</sup></td><td></td></tr><tr><td align="left">TSH</td><td align="left">rs4128956</td><td align="left">131,848,063</td><td align="left">9</td><td align="left">3.6*10<sup>-05</sup></td><td align="left">0.355</td><td></td></tr><tr><td align="left">TSH</td><td align="left">rs7865184</td><td align="left">14,677,867</td><td align="left">9</td><td align="left">3.9*10<sup>-05</sup></td><td align="left">0.082</td><td align="left"><italic>ZDHHC21</italic></td></tr><tr><td align="left">CysC</td><td align="left">rs563754</td><td align="left">61,068,849</td><td align="left">18</td><td align="left">4.7*10<sup>-05</sup></td><td align="left">0.002</td><td></td></tr><tr><td align="left">GFR</td><td align="left">rs2885618</td><td align="left">41,244,839</td><td align="left">18</td><td align="left">4.8*10<sup>-05</sup></td><td align="left">1.0*10<sup>-04</sup></td><td></td></tr><tr><td align="left">TSH</td><td align="left">rs701801</td><td align="left">100,166,859</td><td align="left">10</td><td align="left">5.8*10<sup>-05</sup></td><td align="left">0.090</td><td align="left"><italic>HPS1</italic></td></tr><tr><td align="left">UAE</td><td align="left">rs33855</td><td align="left">171,124,642</td><td align="left">5</td><td align="left">6.2*10<sup>-05</sup></td><td align="left">0.192</td><td></td></tr><tr><td align="left">GFR</td><td align="left">rs10483741</td><td align="left">61,059,454</td><td align="left">14</td><td align="left">6.3*10<sup>-05</sup></td><td align="left">0.298</td><td align="left"><italic>PRKCH</italic></td></tr><tr><td align="left">CysC</td><td align="left">rs2121267</td><td align="left">46,461,040</td><td align="left">2</td><td align="left">6.6*10<sup>-05</sup></td><td align="left">0.002</td><td align="left"><italic>EPAS1</italic></td></tr><tr><td align="left">CysC</td><td align="left">rs1400306</td><td align="left">83,256,163</td><td align="left">11</td><td align="left">7.2*10<sup>-05</sup></td><td align="left">0.061</td><td></td></tr><tr><td align="left">TSH</td><td align="left">rs1223531</td><td align="left">13,255,521</td><td align="left">6</td><td align="left">8.0*10<sup>-05</sup></td><td align="left">0.123</td><td align="left"><italic>PHACTR1</italic></td></tr><tr><td align="left">CysC</td><td align="left">rs10504244</td><td align="left">59,147,328</td><td align="left">8</td><td align="left">8.3*10<sup>-05</sup></td><td align="left">0.005</td><td></td></tr><tr><td align="left">UAE</td><td align="left">rs2374688</td><td align="left">106,175,669</td><td align="left">12</td><td align="left">9.1*10<sup>-05</sup></td><td align="left">0.087</td><td align="left"><italic>BTBD11</italic></td></tr><tr><td align="left">UAE</td><td align="left">rs10519012</td><td align="left">58,333,458</td><td align="left">15</td><td align="left">1.0*10<sup>-04</sup></td><td align="left">0.088</td><td></td></tr><tr><td align="left">CysC</td><td align="left">rs1931619</td><td align="left">82,682,388</td><td align="left">6</td><td align="left">1.0*10<sup>-04</sup></td><td align="left">0.05</td><td></td></tr><tr><td align="left">UAE</td><td align="left">rs10501264</td><td align="left">41,387,406</td><td align="left">11</td><td align="left">1.1*10<sup>-04</sup></td><td align="left">7.2*10<sup>-04</sup></td><td></td></tr><tr><td align="left">UAE</td><td align="left">rs10492025</td><td align="left">111,735,770</td><td align="left">12</td><td align="left">1.1*10<sup>-04</sup></td><td align="left">0.41</td><td align="left"><italic>RPH3A</italic></td></tr><tr><td align="left">UAE</td><td align="left">rs2056694</td><td align="left">128,517,768</td><td align="left">7</td><td align="left">1.1*10<sup>-04</sup></td><td align="left">0.1</td><td></td></tr><tr><td align="left">UAE</td><td align="left">rs8113386</td><td align="left">16,332,871</td><td align="left">19</td><td align="left">1.1*10<sup>-04</sup></td><td align="left">0.053</td><td align="left"><italic>KLF2</italic></td></tr><tr><td align="left">TSH</td><td align="left">rs295136</td><td align="left">200,966,508</td><td align="left">2</td><td align="left">1.3 *10<sup>-04</sup></td><td align="left">0.64</td><td></td></tr><tr><td colspan="7"><hr></hr></td></tr><tr><td align="left" colspan="7"><bold>2c. </bold>Magnitude and Location of Peak LOD scores for regions in which LOD exceeds 2.5.* Corresponding phenotype names on the web are PHOSPHORUSMV2 (serum phosphorous), URICACIDMV2 (uric acid), SCRLNMVNL6 (serum creatinine exam 6), LHMV3 (luteinizing hormone), GFRMVNL6 (GFR exam 6), CALCIUMMV2 (serum calcium), GFRMV7 (GFR exam 7), and SCRLNMVNL5 (serum creatinine exam 5)</td></tr><tr><td colspan="7"><hr></hr></td></tr><tr><td align="left"><bold>Trait</bold></td><td align="center"><bold>SNP</bold></td><td align="center"><bold>Chromosome</bold></td><td align="center"><bold>Physical location (Mb)</bold></td><td align="center"><bold>LOD 1.5 (Lower; Mb)</bold></td><td align="center"><bold>LOD 1.5 (Upper; Mb)</bold></td><td align="center"><bold>LOD</bold></td></tr><tr><td colspan="7"><hr></hr></td></tr><tr><td align="left">Serum Phosphorous</td><td align="center">rs754958</td><td align="center">8</td><td align="center">134307953</td><td align="center">130413367</td><td align="center">139409406</td><td align="center">4.33</td></tr><tr><td align="left">Uric acid</td><td align="center">rs10495487</td><td align="center">2</td><td align="center">2310945</td><td align="center">107241</td><td align="center">3787803</td><td align="center">4.28</td></tr><tr><td align="left">Serum creatinine (exam 6)</td><td align="center">rs10489578</td><td align="center">1</td><td align="center">229251990</td><td align="center">224108350</td><td align="center">230301885</td><td align="center">3.35</td></tr><tr><td align="left">Luteinizing Hormone</td><td align="center">rs10515134</td><td align="center">17</td><td align="center">52218447</td><td align="center">45043525</td><td align="center">59136652</td><td align="center">3.17</td></tr><tr><td align="left">GFR (exam 6)</td><td align="center">rs10489578</td><td align="center">1</td><td align="center">229251990</td><td align="center">220881707</td><td align="center">230301885</td><td align="center">3.08</td></tr><tr><td align="left">Serum Calcium</td><td align="center">rs10484370</td><td align="center">6</td><td align="center">18686366</td><td align="center">10181754</td><td align="center">21792915</td><td align="center">3.03</td></tr><tr><td align="left">GFR (exam 7)</td><td align="center">rs10511176</td><td align="center">3</td><td align="center">100809191</td><td align="center">73551217</td><td align="center">103238533</td><td align="center">2.79</td></tr><tr><td align="left">Serum creatinine (exam 5)</td><td align="center">rs10502302</td><td align="center">18</td><td align="center">2542886</td><td align="center">156277</td><td align="center">3857290</td><td align="center">2.51</td></tr></tbody></table><table-wrap-foot><p>*All traits are multivariable-adjusted; see Table 1 for specific covariate adjustments.</p></table-wrap-foot></table-wrap><p>Table <xref ref-type="table" rid="T2">2c</xref> presents all traits examined with LOD scores of at least 2.5. One locus on chromosome 1 (nearest marker on the 100K GeneChip, rs10489578) was linked to GFR with a LOD score of 3.08. We observed a LOD score of 4.28 for uric acid to chromosome 2 (nearest marker rs10495487), a location we have previously identified using Marshfield linkage analysis to uric acid [<xref ref-type="bibr" rid="B45">45</xref>].</p><p>Table <xref ref-type="table" rid="T3">3</xref> presents the top SNPs for our multiple phenotype analysis for GFR, UAE, and TSH with a total of 24 SNPs showing consistently significant associations with multiple related phenotypes. Tables <xref ref-type="table" rid="T4">4a</xref> and <xref ref-type="table" rid="T4">4b</xref> present results looking at replication of genes that have been associated with kidney traits in the published literature. Four SNPs in or near the <italic>CST</italic>3 gene were highly correlated with cysC levels (p-value 8.5*10<sup>-09 </sup>to 0.007). All four SNPs have minor allele frequencies greater than 10% and none were in linkage disequilibrium (defined by R<sup>2 </sup>&#x0003e; 0.8) as shown on Table <xref ref-type="table" rid="T4">4</xref>. The proportion of the cysC variation that can be explained by these SNPs is shown in Table <xref ref-type="table" rid="T4">4</xref>. rs1158167 accounts for 2.5% of the cysC variation. We found nominal significance between a SNP near the <italic>APOE </italic>gene and CKD (p = 0.04).</p><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>SNPs showing the top 8 significant association with multiple measurements of GFR, UACR, or TSH phenotypes.* Corresponding phenotype names on the web are GFRMV7 (GFR), UAELNMV6 (UAE), and TSHMEAN34MV (TSH).</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left">Trait</td><td align="center">chromosome</td><td align="left">SNP (rsID)</td><td align="left">Physical Location</td><td align="left">Genes (in or near)</td><td align="left">Mean p-value (GEE)</td><td align="right">Mean p-value (FBAT)</td></tr></thead><tbody><tr><td align="left">GFR</td><td align="center">21</td><td align="left">rs2839235</td><td align="right">46625020</td><td align="left"><italic>PCNT2</italic></td><td align="left">6.3*10<sup>-4</sup></td><td align="right">0.281</td></tr><tr><td align="left">GFR</td><td align="center">17</td><td align="left">rs10512437</td><td align="right">27046466</td><td></td><td align="left">0.002</td><td align="right">0.197</td></tr><tr><td align="left">GFR</td><td align="center">13</td><td align="left">rs2480555</td><td align="right">70785310</td><td align="left"><italic>DACH1</italic></td><td align="left">0.003</td><td align="right">0.006</td></tr><tr><td align="left">GFR</td><td align="center">7</td><td align="left">rs10486135</td><td align="right">11301740</td><td></td><td align="left">0.004</td><td align="right">0.142</td></tr><tr><td align="left">GFR</td><td align="center">7</td><td align="left">rs727087</td><td align="right">8244570</td><td align="left"><italic>ICA1</italic></td><td align="left">0.004</td><td align="right">0.223</td></tr><tr><td align="left">GFR</td><td align="center">13</td><td align="left">rs1005066</td><td align="right">70790573</td><td align="left"><italic>DACH1</italic></td><td align="left">0.004</td><td align="right">0.022</td></tr><tr><td align="left">GFR</td><td align="center">18</td><td align="left">rs2885618</td><td align="right">41244839</td><td align="left"><italic>SETBP1</italic></td><td align="left">0.004</td><td align="right">0.024</td></tr><tr><td align="left">GFR</td><td align="center">2</td><td align="left">rs10496887</td><td align="right">142198571</td><td align="left"><italic>LRP1B</italic></td><td align="left">0.005</td><td align="right">0.091</td></tr><tr><td align="left">UAE</td><td align="center">11</td><td align="left">rs1712790</td><td align="right">114126679</td><td align="left"><italic>FAM55D</italic></td><td align="left">9.1*10<sup>-07</sup></td><td align="right">0.009</td></tr><tr><td align="left">UAE</td><td align="center">6</td><td align="left">rs10485409</td><td align="right">91562132</td><td align="left"><italic>EPHA7</italic></td><td align="left">1.0*10<sup>-05</sup></td><td align="right">0.067</td></tr><tr><td align="left">UAE</td><td align="center">21</td><td align="left">rs9305354</td><td align="right">28397067</td><td></td><td align="left">1.9*10<sup>-05</sup></td><td align="right">0.018</td></tr><tr><td align="left">UAE</td><td align="center">11</td><td align="left">rs10502192</td><td align="right">114127562</td><td align="left"><italic>FAM55D</italic></td><td align="left">3.6*10<sup>-05</sup></td><td align="right">0.041</td></tr><tr><td align="left">UAE</td><td align="center">1</td><td align="left">rs2077678</td><td align="right">75246848</td><td></td><td align="left">4.4*10<sup>-05</sup></td><td align="right">0.022</td></tr><tr><td align="left">UAE</td><td align="center">4</td><td align="left">rs723464</td><td align="right">133940196</td><td></td><td align="left">4.9*10<sup>-05</sup></td><td align="right">0.000</td></tr><tr><td align="left">UAE</td><td align="center">21</td><td align="left">rs9305355</td><td align="right">28397088</td><td></td><td align="left">5.0*10<sup>-05</sup></td><td align="right">0.011</td></tr><tr><td align="left">UAE</td><td align="center">6</td><td align="left">rs10484587</td><td align="right">143183270</td><td align="left"><italic>AIG1</italic></td><td align="left">5.2*10<sup>-05</sup></td><td align="right">0.032</td></tr><tr><td align="left">TSH</td><td align="center">7</td><td align="left">rs6977660</td><td align="right">19578720</td><td></td><td align="left">1.6*10<sup>-05</sup></td><td align="right">0.022</td></tr><tr><td align="left">TSH</td><td align="center">4</td><td align="left">rs10493147</td><td align="right">129095104</td><td align="left"><italic>HSPA4L</italic></td><td align="left">2.1*10<sup>-05</sup></td><td align="right">0.019</td></tr><tr><td align="left">TSH</td><td align="center">7</td><td align="left">rs10499559</td><td align="right">21882699</td><td align="left"><italic>DNAH11</italic></td><td align="left">2.8*10<sup>-05</sup></td><td align="right">0.111</td></tr><tr><td align="left">TSH</td><td align="center">6</td><td align="left">rs9322817</td><td align="right">105338926</td><td></td><td align="left">7.4*10<sup>-05</sup></td><td align="right">0.576</td></tr><tr><td align="left">TSH</td><td align="center">2</td><td align="left">rs9308765</td><td align="right">118759439</td><td align="left"><italic>INSIG2</italic></td><td align="left">7.7*10<sup>-05</sup></td><td align="right">0.404</td></tr><tr><td align="left">TSH</td><td align="center">6</td><td align="left">rs6942231</td><td align="right">105298507</td><td></td><td align="left">1.6*10<sup>-04</sup></td><td align="right">0.541</td></tr><tr><td align="left">TSH</td><td align="center">7</td><td align="left">rs10486365</td><td align="right">19574604</td><td></td><td align="left">1.9*10<sup>-04</sup></td><td align="right">0.221</td></tr><tr><td align="left">TSH</td><td align="center">7</td><td align="left">rs10486653</td><td align="right">34484903</td><td align="left"><italic>BMPER</italic></td><td align="left">2.7*10<sup>-04</sup></td><td align="right">0.252</td></tr></tbody></table><table-wrap-foot><p>*see details in methods for criteria for generating mean p-value</p></table-wrap-foot></table-wrap><table-wrap position="float" id="T4"><label>Table 4</label><caption><p>Results on Association Analysis for Candidate Genes</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left" colspan="8"><bold>4a. </bold>Results of GEE analysis between SNPs in the <italic>CST</italic>3 and <italic>APOE </italic>candidate genes and the kidney function traits with p-value &#x0003c; 0.05. Corresponding phenotype names on the web are CYSMV7 (CysC) and CKDMV7 (CKD).</td></tr></thead><tbody><tr><td align="left"><bold>Candidate gene</bold></td><td align="left"><bold>PHENOTYPE</bold></td><td align="left"><bold>SNP</bold></td><td align="center"><bold>CHROMOSOME</bold></td><td align="center"><bold>Location</bold></td><td align="center"><bold>Minor allele frequency(%)</bold></td><td align="center"><bold>P_value (GEE)</bold></td><td align="center"><bold>Partial R<sup>2</sup></bold></td></tr><tr><td colspan="8"><hr></hr></td></tr><tr><td align="left"><italic>CST3</italic></td><td align="left">CysC</td><td align="left">rs1158167</td><td align="center">20</td><td align="center">23,526,189</td><td align="center">21</td><td align="center">8.0 *10<sup>-9</sup></td><td align="center">2.5</td></tr><tr><td align="left"><italic>CST3</italic></td><td align="left">CysC</td><td align="left">rs2145231</td><td align="center">20</td><td align="center">23,573,547</td><td align="center">15</td><td align="center">1.1*10<sup>-5</sup></td><td align="center">1.2</td></tr><tr><td align="left"><italic>CST3</italic></td><td align="left">CysC</td><td align="left">rs726217</td><td align="center">20</td><td align="center">23,532,116</td><td align="center">38</td><td align="center">3.1*10<sup>-4</sup></td><td align="center">0.8</td></tr><tr><td align="left"><italic>CST3</italic></td><td align="left">CysC</td><td align="left">rs911122</td><td align="center">20</td><td align="center">23,573,746</td><td align="center">37</td><td align="center">0.007</td><td align="center">1.1</td></tr><tr><td align="left"><italic>APOE</italic></td><td align="left">CKD</td><td align="left">rs3760626</td><td align="center">19</td><td align="center">50,148,945</td><td align="center">45</td><td align="center">0.04</td><td align="center">-</td></tr><tr><td colspan="8"><hr></hr></td></tr><tr><td align="left" colspan="8"><bold>4b. </bold>Results of FBAT analysis between SNPs in the <italic>CST</italic>3 candidate gene and kidney function traits with p-value &#x0003c; 0.05. Corresponding phenotype names on the web are CYSMV7 (CysC) and UAEGE30HTNMV6 (UAE &#x02265; 30 mg/g)</td></tr><tr><td colspan="8"><hr></hr></td></tr><tr><td align="left"><bold>Candidate gene</bold></td><td align="left"><bold>PHENOTYPE</bold></td><td align="left"><bold>SNP</bold></td><td align="center"><bold>CHROMOSOME</bold></td><td align="center"><bold>Location</bold></td><td align="center"><bold>P-value</bold></td><td></td><td></td></tr><tr><td colspan="8"><hr></hr></td></tr><tr><td align="left"><italic>CST3</italic></td><td align="left">CysC</td><td align="left">rs1158167</td><td align="center">20</td><td align="center">23,526,189</td><td align="center">0.006</td><td></td><td></td></tr><tr><td align="left"><italic>CST3</italic></td><td align="left">CysC</td><td align="left">rs2145231</td><td align="center">20</td><td align="center">23,573,547</td><td align="center">0.011</td><td></td><td></td></tr><tr><td align="left"><italic>CST3</italic></td><td align="left">UAE &#x02265; 30*</td><td align="left">rs911122</td><td align="center">20</td><td align="center">23,573,746</td><td align="center">0.032</td><td></td><td></td></tr></tbody></table><table-wrap-foot><p>*In a sample enriched for hypertensive individuals</p></table-wrap-foot></table-wrap><sec><title>Additional findings</title><p>We also identified several other plausible candidate genes that appear in our list of top 500 SNPs for each trait (see <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?id=phs000007"/>). For GFR, we identified <italic>LRP1B </italic>(GEE p-value = 0.0006, rs1049688), <italic>ADRBK2 </italic>(GEE p-value = 0.002, rs1048312), <italic>APOB </italic>(GEE p-value = 0.003, rs1048312), several genes in the chromosome 17 cytokine gene cluster including <italic>CCL3</italic>, <italic>CCL4</italic>, and <italic>CCL18 </italic>(GEE p-value 0.004, rs1818816), <italic>SCARB1 </italic>(GEE p-value = 0.004, rs1902569), <italic>NFKB1 </italic>(FBAT p-value = 0.001, rs230489), <italic>TGFB1 </italic>(FBAT p-value = 0.003, rs2072239), and <italic>PPARG </italic>(FBAT p-value = 0.005, rs709157). For UAE, we also identified a SNP in the <italic>LRP1B </italic>gene (GEE p-value = 0.004, rs1049687). For cysC, we identified SNPs in the <italic>LRP1B </italic>gene (GEE p-value = 0.001, rs1463615), <italic>ANGPT1 </italic>(GEE p-value = 0.005, rs4354281), <italic>NFKB1 </italic>(FBAT p-value = 0.004, rs2991716), and <italic>PPARG </italic>(FBAT p-value = 0.004, rs1051041). For mean TSH, we identified SNPs in <italic>ADRBK2 </italic>(GEE p-value = 0.002, rs3888397), <italic>TRHDE </italic>(GEE p-value = 0.002, rs2044305) and <italic>DIO2 </italic>(GEE p-value = 0.003, rs54566), the <italic>SCD</italic>4 gene (rs10516679 GEE p-value = 0.0007 FBAT p-value = 0.02), <italic>VLDLR </italic>(FBAT p-value = 0.002, rs4084415) and <italic>APOBEC2P </italic>(FBAT p-value = 0.005, rs722442).</p></sec></sec><sec><title>Discussion</title><p>In our analysis of kidney-related traits, we have found strong evidence for association between multiple kidney-related traits and TSH with SNPs on the Affymetrix 100K GeneChip. We found strong evidence for association between cysC levels and 4 SNPs in or near the <italic>CST</italic>3 gene. For UAE, we observed strong association with <italic>ADAM23</italic>, a gene involved in the metalloproteinase family, which may be involved in the pathophysiology of glomerulosclerosis [<xref ref-type="bibr" rid="B46">46</xref>], and <italic>PCDH9</italic>, a gene that is a member of the cadherin superfamily. For TSH, we observed significant association with the <italic>HSPA4L </italic>gene with a mean p-value for all three TSH measurements, a gene that is part of the heat shock protein family, which may be involved in the pathophysiology of thyroid disease [<xref ref-type="bibr" rid="B47">47</xref>]. We also observed association with the <italic>SCD</italic>4 gene, a gene involved in the conversion of saturated to monounsaturated fatty acids; TSH is an important correlate of lipid levels [<xref ref-type="bibr" rid="B48">48</xref>].</p><p>In our linkage results, we observed a region we have previously noted for uric acid [<xref ref-type="bibr" rid="B45">45</xref>], albeit with a significantly higher LOD score. We identified a LOD score of 2.78 on chromosome 3, approximately 18 Mb away from a region previously noted in association with kidney function in hypertensive individuals [<xref ref-type="bibr" rid="B17">17</xref>], a region that lies within our 1.5 support LOD interval. We also report novel loci for GFR and TSH.</p><p>We show significant association between cysC levels and the <italic>CST</italic>3 gene, an observation that has been previously noted [<xref ref-type="bibr" rid="B49">49</xref>]. Our top SNP reaches genome-wide significance, and may represent a true finding. In our candidate gene approach, we found nominal significance for a SNP near the <italic>APOE </italic>gene, a gene that has been associated with CKD [<xref ref-type="bibr" rid="B50">50</xref>]. Unfortunately, poor coverage of the <italic>APOE </italic>gene by the Affymetrix 100K Genechip precluded a more in-depth test of association with SNPs in the <italic>APOE </italic>gene and CKD.</p><p>Strengths of our study lie in our assessment of multiple measures of kidney function and endocrine traits in a sample unselected for these traits, thus reducing bias. We also have excellent assessment of potential confounders that we are able to adjust for in our residual creation. Because the Framingham Heart Study has measured multiple traits, we are able to examine phenotype clustering. Limitations exist as well. Kidney function was ascertained by a single serum creatinine measure, which may lead to misclassification. Our sample was not selected for CKD, and as a result, affected individuals had moderate CKD as reflected by the median eGFR of 53.7 ml/min/1.73 m<sup>2 </sup>among participants with CKD. The MDRD equation, which was used to estimate GFR, has been shown to underestimate GFR by 29% in healthy individuals [<xref ref-type="bibr" rid="B51">51</xref>]; therefore, we may have introduced additional misclassification into our trait definition. We used a spot urine specimen to assess UAE instead of a 24-hour collection. However, spot UAE approximates 24-hour collections [<xref ref-type="bibr" rid="B40">40</xref>], and are not prone to the error inherent in collecting 24-hour urine specimens. We used cysC as a continuous trait and did not use transforming equations to estimate GFR, as most existing equations have been developed in small, selected samples [<xref ref-type="bibr" rid="B52">52</xref>,<xref ref-type="bibr" rid="B53">53</xref>], or developed using immunoturbimetric method [<xref ref-type="bibr" rid="B53">53</xref>,<xref ref-type="bibr" rid="B54">54</xref>] instead of nephelometry and therefore we did not feel as though they were appropriate for use in our large population-based cohort. Further, we used cystatin C as a marker of kidney function but can not rule out that it may also reflect cardiovascular disease risk above and beyond its relation to kidney function [<xref ref-type="bibr" rid="B55">55</xref>-<xref ref-type="bibr" rid="B59">59</xref>]. Our focus on multivariable models may have led us to miss important bivariate associations between SNPs and measures of kidney function. Given that our findings have not yet been replicated, many p-values may represent false positive findings. We used TSH as an indicator of thyroid function, as we do not have measures of free thyroxine or a reliable assessment of thyroid disease in our study sample. Our sample is neither ethnically diverse nor nationally representative, and it is uncertain how our results would apply to other ethnic groups. However, in genetics studies, sample homogeneity is beneficial in order to reduce population stratification. For limitations pertaining to our genotyping or statistical methods, please see the Overview [<xref ref-type="bibr" rid="B37">37</xref>].</p></sec><sec><title>Conclusion</title><p>Kidney function traits and TSH are associated with SNPs on the Affymetrix 100K SNP GeneChip. Replication of association between these traits and SNPs requires follow-up in independent samples. These data will serve as a valuable resource for replication as more SNPs associated with kidney function and endocrine traits are identified.</p></sec><sec><title>Abbreviations</title><p>CKD = chronic kidney disease; cysC = cystatin-C; DHEAS = dehydroepiandrosterone sulfate; FBAT = family-based association tests; FSH = follicle stimulating hormone; GEE = generalized estimating equations; GFR = glomerular filtration rate; LD = linkage disequilibrium; LH = luteinizing hormone; MDRD = Modification of Diet in Renal Disease; SNP = single nucleotide polymorphism; TSH = thyroid stimulating hormone; UAE = urinary albumin excretion.</p></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec><title>Authors' contributions</title><p>SH generated the phenotype data, participated in the analysis, and drafted the manuscript. CF helped generate the phenotype data, interpret the results, and draft the manuscript. QY generated the phenotype data, interpreted the results, and helped draft the manuscript. JBM helped generate the phenotype data, interpret the results, and revised the manuscript critically for important intellectual content; and has given final approval of the version to be published. EP assisted in the acquisition and cleaning of the TSH data and critically reviewed a draft of the manuscript. All authors gave final approval to the manuscript.</p></sec></body><back><ack><sec><title>Acknowledgements</title><p>The Framingham Study is supported by N01-HC 25195. Dr Meigs is supported by an American Diabetes Association Career Development Award. The study was also supported by donation of urinary albumin excretion assay reagents from Roche Diagnostics Inc. A portion of the research was conducted using the BU Linux Cluster for Genetic Analysis (LinGA) funded by the NIH NCRR (National Center for Research Resources) Shared Instrumentation grant (1S10RR163736-01A1). The investigators would like to recognize the Framingham Heart Study participants and the following collaborators: Martin Larson, Daniel Levy, Emelia J. Benjamin, Joanne M. Murabito, and Ramachandran S. Vasan.</p><p>This article has been published as part of <italic>BMC Medical Genetics </italic>Volume 8 Supplement 1, 2007: The Framingham Heart Study 100,000 single nucleotide polymorphisms resource. The full contents of the supplement are available online at <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2350/8?issue=S1"/>.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Coresh</surname><given-names>J</given-names></name><name><surname>Astor</surname><given-names>BC</given-names></name><name><surname>Greene</surname><given-names>T</given-names></name><name><surname>Eknoyan</surname><given-names>G</given-names></name><name><surname>Levey</surname><given-names>AS</given-names></name></person-group><article-title>Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey</article-title><source>Am J Kidney Dis</source><year>2003</year><volume>41</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">12500213</pub-id><pub-id pub-id-type="doi">10.1053/ajkd.2003.50007</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Manjunath</surname><given-names>G</given-names></name><name><surname>Tighiouart</surname><given-names>H</given-names></name><name><surname>Ibrahim</surname><given-names>H</given-names></name><name><surname>MacLeod</surname><given-names>B</given-names></name><name><surname>Salem</surname><given-names>DN</given-names></name><name><surname>Griffith</surname><given-names>JL</given-names></name><name><surname>Coresh</surname><given-names>J</given-names></name><name><surname>Levey</surname><given-names>AS</given-names></name><name><surname>Sarnak</surname><given-names>MJ</given-names></name></person-group><article-title>Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community</article-title><source>J Am Coll Cardiol</source><year>2003</year><volume>41</volume><fpage>47</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">12570944</pub-id><pub-id pub-id-type="doi">10.1016/S0735-1097(02)02663-3</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Manjunath</surname><given-names>G</given-names></name><name><surname>Tighiouart</surname><given-names>H</given-names></name><name><surname>Coresh</surname><given-names>J</given-names></name><name><surname>MacLeod</surname><given-names>B</given-names></name><name><surname>Salem</surname><given-names>DN</given-names></name><name><surname>Griffith</surname><given-names>JL</given-names></name><name><surname>Levey</surname><given-names>AS</given-names></name><name><surname>Sarnak</surname><given-names>MJ</given-names></name></person-group><article-title>Level of kidney function as a risk factor for cardiovascular outcomes in the elderly</article-title><source>Kidney Int</source><year>2003</year><volume>63</volume><fpage>1121</fpage><lpage>1129</lpage><pub-id pub-id-type="pmid">12631096</pub-id><pub-id pub-id-type="doi">10.1046/j.1523-1755.2003.00838.x</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mann</surname><given-names>JF</given-names></name><name><surname>Gerstein</surname><given-names>HC</given-names></name><name><surname>Pogue</surname><given-names>J</given-names></name><name><surname>Bosch</surname><given-names>J</given-names></name><name><surname>Yusuf</surname><given-names>S</given-names></name></person-group><article-title>Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial</article-title><source>Ann Intern Med</source><year>2001</year><volume>134</volume><fpage>629</fpage><lpage>636</lpage><pub-id pub-id-type="pmid">11304102</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fried</surname><given-names>LF</given-names></name><name><surname>Shlipak</surname><given-names>MG</given-names></name><name><surname>Crump</surname><given-names>C</given-names></name><name><surname>Bleyer</surname><given-names>AJ</given-names></name><name><surname>Gottdiener</surname><given-names>JS</given-names></name><name><surname>Kronmal</surname><given-names>RA</given-names></name><name><surname>Kuller</surname><given-names>LH</given-names></name><name><surname>Newman</surname><given-names>AB</given-names></name></person-group><article-title>Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals</article-title><source>J Am Coll Cardiol</source><year>2003</year><volume>41</volume><fpage>1364</fpage><lpage>1372</lpage><pub-id pub-id-type="pmid">12706933</pub-id><pub-id pub-id-type="doi">10.1016/S0735-1097(03)00163-3</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>O'Hare</surname><given-names>AM</given-names></name><name><surname>Vittinghoff</surname><given-names>E</given-names></name><name><surname>Hsia</surname><given-names>J</given-names></name><name><surname>Shlipak</surname><given-names>MG</given-names></name></person-group><article-title>Renal insufficiency and the risk of lower extremity peripheral arterial disease: results from the heart and estrogen/progestin replacement study (HERS)</article-title><source>J Am Soc Nephrol</source><year>2004</year><volume>15</volume><fpage>1046</fpage><lpage>1051</lpage><pub-id pub-id-type="pmid">15034108</pub-id><pub-id pub-id-type="doi">10.1097/01.ASN.0000119574.27772.FD</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weiner</surname><given-names>DE</given-names></name><name><surname>Tighiouart</surname><given-names>H</given-names></name><name><surname>Amin</surname><given-names>MG</given-names></name><name><surname>Stark</surname><given-names>PC</given-names></name><name><surname>MacLeod</surname><given-names>B</given-names></name><name><surname>Griffith</surname><given-names>JL</given-names></name><name><surname>Salem</surname><given-names>DN</given-names></name><name><surname>Levey</surname><given-names>AS</given-names></name><name><surname>Sarnak</surname><given-names>MJ</given-names></name></person-group><article-title>Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies</article-title><source>J Am Soc Nephrol</source><year>2004</year><volume>15</volume><fpage>1307</fpage><lpage>1315</lpage><pub-id pub-id-type="pmid">15100371</pub-id><pub-id pub-id-type="doi">10.1097/01.ASN.0000123691.46138.E2</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Culleton</surname><given-names>BF</given-names></name><name><surname>Larson</surname><given-names>MG</given-names></name><name><surname>Wilson</surname><given-names>PW</given-names></name><name><surname>Evans</surname><given-names>JC</given-names></name><name><surname>Parfrey</surname><given-names>PS</given-names></name><name><surname>Levy</surname><given-names>D</given-names></name></person-group><article-title>Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency</article-title><source>Kidney Int</source><year>1999</year><volume>56</volume><fpage>2214</fpage><lpage>2219</lpage><pub-id pub-id-type="pmid">10594797</pub-id><pub-id pub-id-type="doi">10.1046/j.1523-1755.1999.00773.x</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fox</surname><given-names>CS</given-names></name><name><surname>Larson</surname><given-names>MG</given-names></name><name><surname>Leip</surname><given-names>EP</given-names></name><name><surname>Culleton</surname><given-names>B</given-names></name><name><surname>Wilson</surname><given-names>PW</given-names></name><name><surname>Levy</surname><given-names>D</given-names></name></person-group><article-title>Predictors of new-onset kidney disease in a community-based population</article-title><source>JAMA</source><year>2004</year><volume>291</volume><fpage>844</fpage><lpage>850</lpage><pub-id pub-id-type="pmid">14970063</pub-id><pub-id pub-id-type="doi">10.1001/jama.291.7.844</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Muntner</surname><given-names>P</given-names></name><name><surname>Hamm</surname><given-names>LL</given-names></name><name><surname>Kusek</surname><given-names>JW</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Whelton</surname><given-names>PK</given-names></name><name><surname>He</surname><given-names>J</given-names></name></person-group><article-title>The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease</article-title><source>Ann Intern Med</source><year>2004</year><volume>140</volume><fpage>9</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">14706967</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Adler</surname><given-names>AI</given-names></name><name><surname>Stevens</surname><given-names>RJ</given-names></name><name><surname>Manley</surname><given-names>SE</given-names></name><name><surname>Bilous</surname><given-names>RW</given-names></name><name><surname>Cull</surname><given-names>CA</given-names></name><name><surname>Holman</surname><given-names>RR</given-names></name></person-group><article-title>Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64)</article-title><source>Kidney Int</source><year>2003</year><volume>63</volume><fpage>225</fpage><lpage>232</lpage><pub-id pub-id-type="pmid">12472787</pub-id><pub-id pub-id-type="doi">10.1046/j.1523-1755.2003.00712.x</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>RG</given-names></name><name><surname>Bennett</surname><given-names>PH</given-names></name><name><surname>Beck</surname><given-names>GJ</given-names></name><name><surname>Tan</surname><given-names>M</given-names></name><name><surname>Knowler</surname><given-names>WC</given-names></name><name><surname>Mitch</surname><given-names>WE</given-names></name><name><surname>Hirschman</surname><given-names>GH</given-names></name><name><surname>Myers</surname><given-names>BD</given-names></name></person-group><article-title>Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group</article-title><source>N Engl J Med</source><year>1996</year><volume>335</volume><fpage>1636</fpage><lpage>1642</lpage><pub-id pub-id-type="pmid">8929360</pub-id><pub-id pub-id-type="doi">10.1056/NEJM199611283352203</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peterson</surname><given-names>JC</given-names></name><name><surname>Adler</surname><given-names>S</given-names></name><name><surname>Burkart</surname><given-names>JM</given-names></name><name><surname>Greene</surname><given-names>T</given-names></name><name><surname>Hebert</surname><given-names>LA</given-names></name><name><surname>Hunsicker</surname><given-names>LG</given-names></name><name><surname>King</surname><given-names>AJ</given-names></name><name><surname>Klahr</surname><given-names>S</given-names></name><name><surname>Massry</surname><given-names>SG</given-names></name><name><surname>Seifter</surname><given-names>JL</given-names></name></person-group><article-title>Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study</article-title><source>Ann Intern Med</source><year>1995</year><volume>123</volume><fpage>754</fpage><lpage>762</lpage><pub-id pub-id-type="pmid">7574193</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maschio</surname><given-names>G</given-names></name><name><surname>Alberti</surname><given-names>D</given-names></name><name><surname>Janin</surname><given-names>G</given-names></name><name><surname>Locatelli</surname><given-names>F</given-names></name><name><surname>Mann</surname><given-names>JF</given-names></name><name><surname>Motolese</surname><given-names>M</given-names></name><name><surname>Ponticelli</surname><given-names>C</given-names></name><name><surname>Ritz</surname><given-names>E</given-names></name><name><surname>Zucchelli</surname><given-names>P</given-names></name></person-group><article-title>Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group</article-title><source>N Engl J Med</source><year>1996</year><volume>334</volume><fpage>939</fpage><lpage>945</lpage><pub-id pub-id-type="pmid">8596594</pub-id><pub-id pub-id-type="doi">10.1056/NEJM199604113341502</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garg</surname><given-names>AX</given-names></name><name><surname>Kiberd</surname><given-names>BA</given-names></name><name><surname>Clark</surname><given-names>WF</given-names></name><name><surname>Haynes</surname><given-names>RB</given-names></name><name><surname>Clase</surname><given-names>CM</given-names></name></person-group><article-title>Albuminuria and renal insufficiency prevalence guides population screening: results from the NHANES III</article-title><source>Kidney Int</source><year>2002</year><volume>61</volume><fpage>2165</fpage><lpage>2175</lpage><pub-id pub-id-type="pmid">12028457</pub-id><pub-id pub-id-type="doi">10.1046/j.1523-1755.2002.00356.x</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lei</surname><given-names>HH</given-names></name><name><surname>Perneger</surname><given-names>TV</given-names></name><name><surname>Klag</surname><given-names>MJ</given-names></name><name><surname>Whelton</surname><given-names>PK</given-names></name><name><surname>Coresh</surname><given-names>J</given-names></name></person-group><article-title>Familial aggregation of renal disease in a population-based case-control study</article-title><source>J Am Soc Nephrol</source><year>1998</year><volume>9</volume><fpage>1270</fpage><lpage>1276</lpage><pub-id pub-id-type="pmid">9644638</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>DeWan</surname><given-names>AT</given-names></name><name><surname>Arnett</surname><given-names>DK</given-names></name><name><surname>Atwood</surname><given-names>LD</given-names></name><name><surname>Province</surname><given-names>MA</given-names></name><name><surname>Lewis</surname><given-names>CE</given-names></name><name><surname>Hunt</surname><given-names>SC</given-names></name><name><surname>Eckfeldt</surname><given-names>J</given-names></name></person-group><article-title>A genome scan for renal function among hypertensives: the HyperGEN study</article-title><source>Am J Hum Genet</source><year>2001</year><volume>68</volume><fpage>136</fpage><lpage>144</lpage><pub-id pub-id-type="pmid">11115379</pub-id><pub-id pub-id-type="doi">10.1086/316927</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cohn</surname><given-names>DH</given-names></name><name><surname>Shohat</surname><given-names>T</given-names></name><name><surname>Yahav</surname><given-names>M</given-names></name><name><surname>Ilan</surname><given-names>T</given-names></name><name><surname>Rechavi</surname><given-names>G</given-names></name><name><surname>King</surname><given-names>L</given-names></name><name><surname>Shohat</surname><given-names>M</given-names></name></person-group><article-title>A locus for an autosomal dominant form of progressive renal failure and hypertension at chromosome 1q21</article-title><source>Am J Hum Genet</source><year>2000</year><volume>67</volume><fpage>647</fpage><lpage>651</lpage><pub-id pub-id-type="pmid">10930359</pub-id><pub-id pub-id-type="doi">10.1086/303051</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Freedman</surname><given-names>BI</given-names></name><name><surname>Rich</surname><given-names>SS</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name><name><surname>Roh</surname><given-names>BH</given-names></name><name><surname>Bowden</surname><given-names>DW</given-names></name></person-group><article-title>Linkage heterogeneity of end-stage renal disease on human chromosome 10</article-title><source>Kidney Int</source><year>2002</year><volume>62</volume><fpage>770</fpage><lpage>774</lpage><pub-id pub-id-type="pmid">12164858</pub-id><pub-id pub-id-type="doi">10.1046/j.1523-1755.2002.00534.x</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hunt</surname><given-names>SC</given-names></name><name><surname>Hasstedt</surname><given-names>SJ</given-names></name><name><surname>Coon</surname><given-names>H</given-names></name><name><surname>Camp</surname><given-names>NJ</given-names></name><name><surname>Cawthon</surname><given-names>RM</given-names></name><name><surname>Wu</surname><given-names>LL</given-names></name><name><surname>Hopkins</surname><given-names>PN</given-names></name></person-group><article-title>Linkage of creatinine clearance to chromosome 10 in Utah pedigrees replicates a locus for end-stage renal disease in humans and renal failure in the fawn-hooded rat</article-title><source>Kidney Int</source><year>2002</year><volume>62</volume><fpage>1143</fpage><lpage>1148</lpage><pub-id pub-id-type="pmid">12234284</pub-id><pub-id pub-id-type="doi">10.1111/j.1523-1755.2002.kid557.x</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hunt</surname><given-names>SC</given-names></name><name><surname>Coon</surname><given-names>H</given-names></name><name><surname>Hasstedt</surname><given-names>SJ</given-names></name><name><surname>Cawthon</surname><given-names>RM</given-names></name><name><surname>Camp</surname><given-names>NJ</given-names></name><name><surname>Wu</surname><given-names>LL</given-names></name><name><surname>Hopkins</surname><given-names>PN</given-names></name></person-group><article-title>Linkage of serum creatinine and glomerular filtration rate to chromosome 2 in Utah pedigrees</article-title><source>Am J Hypertens</source><year>2004</year><volume>17</volume><fpage>511</fpage><lpage>515</lpage><pub-id pub-id-type="pmid">15177524</pub-id><pub-id pub-id-type="doi">10.1016/j.amjhyper.2004.02.019</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Placha</surname><given-names>G</given-names></name><name><surname>Poznik</surname><given-names>GD</given-names></name><name><surname>Dunn</surname><given-names>J</given-names></name><name><surname>Smiles</surname><given-names>A</given-names></name><name><surname>Krolewski</surname><given-names>B</given-names></name><name><surname>Glew</surname><given-names>T</given-names></name><name><surname>Puppala</surname><given-names>S</given-names></name><name><surname>Schneider</surname><given-names>J</given-names></name><name><surname>Rogus</surname><given-names>JJ</given-names></name><name><surname>Rich</surname><given-names>SS</given-names></name><name><surname>Duggirala</surname><given-names>R</given-names></name><name><surname>Warram</surname><given-names>JH</given-names></name><name><surname>Krolewski</surname><given-names>AS</given-names></name></person-group><article-title>A genome-wide linkage scan for genes controlling variation in renal function estimated by serum cystatin C levels in extended families with type 2 diabetes</article-title><source>Diabetes</source><year>2006</year><volume>55</volume><fpage>3358</fpage><lpage>3365</lpage><pub-id pub-id-type="pmid">17130480</pub-id><pub-id pub-id-type="doi">10.2337/db06-0781</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fox</surname><given-names>CS</given-names></name><name><surname>Yang</surname><given-names>Q</given-names></name><name><surname>Cupples</surname><given-names>LA</given-names></name><name><surname>Guo</surname><given-names>CY</given-names></name><name><surname>Larson</surname><given-names>MG</given-names></name><name><surname>Leip</surname><given-names>EP</given-names></name><name><surname>Wilson</surname><given-names>PW</given-names></name><name><surname>Levy</surname><given-names>D</given-names></name></person-group><article-title>Genomewide Linkage Analysis to Serum Creatinine, GFR, and Creatinine Clearance in a Community-Based Population: The Framingham Heart Study</article-title><source>J Am Soc Nephrol</source><year>2004</year><volume>15</volume><fpage>2457</fpage><lpage>2461</lpage><pub-id pub-id-type="pmid">15339995</pub-id><pub-id pub-id-type="doi">10.1097/01.ASN.0000135972.13396.6F</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pontiroli</surname><given-names>AE</given-names></name><name><surname>Monti</surname><given-names>LD</given-names></name><name><surname>Pizzini</surname><given-names>A</given-names></name><name><surname>Piatti</surname><given-names>P</given-names></name></person-group><article-title>Familial clustering of arterial blood pressure, HDL cholesterol, and pro-insulin but not of insulin resistance and microalbuminuria in siblings of patients with type 2 diabetes</article-title><source>Diabetes Care</source><year>2000</year><volume>23</volume><fpage>1359</fpage><lpage>1364</lpage><pub-id pub-id-type="pmid">10977033</pub-id><pub-id pub-id-type="doi">10.2337/diacare.23.9.1359</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Forsblom</surname><given-names>CM</given-names></name><name><surname>Kanninen</surname><given-names>T</given-names></name><name><surname>Lehtovirta</surname><given-names>M</given-names></name><name><surname>Saloranta</surname><given-names>C</given-names></name><name><surname>Groop</surname><given-names>LC</given-names></name></person-group><article-title>Heritability of albumin excretion rate in families of patients with Type II diabetes</article-title><source>Diabetologia</source><year>1999</year><volume>42</volume><fpage>1359</fpage><lpage>1366</lpage><pub-id pub-id-type="pmid">10550421</pub-id><pub-id pub-id-type="doi">10.1007/s001250051450</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Freedman</surname><given-names>BI</given-names></name><name><surname>Beck</surname><given-names>SR</given-names></name><name><surname>Rich</surname><given-names>SS</given-names></name><name><surname>Heiss</surname><given-names>G</given-names></name><name><surname>Lewis</surname><given-names>CE</given-names></name><name><surname>Turner</surname><given-names>S</given-names></name><name><surname>Province</surname><given-names>MA</given-names></name><name><surname>Schwander</surname><given-names>KL</given-names></name><name><surname>Arnett</surname><given-names>DK</given-names></name><name><surname>Mellen</surname><given-names>BG</given-names></name></person-group><article-title>A genome-wide scan for urinary albumin excretion in hypertensive families</article-title><source>Hypertension</source><year>2003</year><volume>42</volume><fpage>291</fpage><lpage>296</lpage><pub-id pub-id-type="pmid">12925555</pub-id><pub-id pub-id-type="doi">10.1161/01.HYP.0000087890.33245.41</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Iyengar</surname><given-names>SK</given-names></name><name><surname>Fox</surname><given-names>KA</given-names></name><name><surname>Schachere</surname><given-names>M</given-names></name><name><surname>Manzoor</surname><given-names>F</given-names></name><name><surname>Slaughter</surname><given-names>ME</given-names></name><name><surname>Covic</surname><given-names>AM</given-names></name><name><surname>Orloff</surname><given-names>SM</given-names></name><name><surname>Hayden</surname><given-names>PS</given-names></name><name><surname>Olson</surname><given-names>JM</given-names></name><name><surname>Schelling</surname><given-names>JR</given-names></name><name><surname>Sedor</surname><given-names>JR</given-names></name></person-group><article-title>Linkage analysis of candidate loci for end-stage renal disease due to diabetic nephropathy</article-title><source>J Am Soc Nephrol</source><year>2003</year><volume>14</volume><fpage>S195</fpage><lpage>S201</lpage><pub-id pub-id-type="pmid">12819328</pub-id><pub-id pub-id-type="doi">10.1097/01.ASN.0000070078.66465.55</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>KW</given-names></name><name><surname>Ferrell</surname><given-names>RE</given-names></name><name><surname>Ellis</surname><given-names>D</given-names></name><name><surname>Barmada</surname><given-names>M</given-names></name><name><surname>Moritz</surname><given-names>M</given-names></name><name><surname>Finegold</surname><given-names>DN</given-names></name><name><surname>Jaffe</surname><given-names>R</given-names></name><name><surname>Vats</surname><given-names>A</given-names></name></person-group><article-title>African American hypertensive nephropathy maps to a new locus on chromosome 9q31&#x02013;q32</article-title><source>Am J Hum Genet</source><year>2003</year><volume>73</volume><fpage>420</fpage><lpage>429</lpage><pub-id pub-id-type="pmid">12840782</pub-id><pub-id pub-id-type="doi">10.1086/377184</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fox</surname><given-names>CS</given-names></name><name><surname>Yang</surname><given-names>Q</given-names></name><name><surname>Guo</surname><given-names>CY</given-names></name><name><surname>Cupples</surname><given-names>LA</given-names></name><name><surname>Wilson</surname><given-names>PW</given-names></name><name><surname>Levy</surname><given-names>D</given-names></name><name><surname>Meigs</surname><given-names>JB</given-names></name></person-group><article-title>Genome-wide linkage analysis to urinary microalbuminuria in a community-based sample: The Framingham Heart Study</article-title><source>Kidney Int</source><year>2005</year><volume>67</volume><fpage>70</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">15610229</pub-id><pub-id pub-id-type="doi">10.1111/j.1523-1755.2005.00056.x</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>R</given-names></name><name><surname>Stanbury</surname><given-names>JB</given-names></name></person-group><article-title>Familial studies of autoimmune thyroiditis</article-title><source>Clin Exp Immunol</source><year>1967</year><volume>2</volume></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tomer</surname><given-names>Y</given-names></name><name><surname>Barbesino</surname><given-names>G</given-names></name><name><surname>Greenberg</surname><given-names>DA</given-names></name><name><surname>Concepcion</surname><given-names>E</given-names></name><name><surname>Davies</surname><given-names>TF</given-names></name></person-group><article-title>Mapping the major susceptibility loci for familial Graves' and Hashimoto's diseases: evidence for genetic heterogeneity and gene interactions</article-title><source>J Clin Endocrinol Metab</source><year>1999</year><volume>84</volume><fpage>4656</fpage><lpage>4664</lpage><pub-id pub-id-type="pmid">10599734</pub-id><pub-id pub-id-type="doi">10.1210/jc.84.12.4656</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Samollow</surname><given-names>PB</given-names></name><name><surname>Perez</surname><given-names>G</given-names></name><name><surname>Kammerer</surname><given-names>CM</given-names></name><name><surname>Finegold</surname><given-names>D</given-names></name><name><surname>Zwartjes</surname><given-names>PW</given-names></name><name><surname>Havill</surname><given-names>LM</given-names></name><name><surname>Comuzzie</surname><given-names>AG</given-names></name><name><surname>Mahaney</surname><given-names>MC</given-names></name><name><surname>Goring</surname><given-names>HH</given-names></name><name><surname>Blangero</surname><given-names>J</given-names></name><name><surname>Foley</surname><given-names>TP</given-names></name><name><surname>Barmada</surname><given-names>MM</given-names></name></person-group><article-title>Genetic and environmental influences on thyroid hormone variation in Mexican Americans</article-title><source>J Clin Endocrinol Metab</source><year>2004</year><volume>89</volume><fpage>3276</fpage><lpage>3284</lpage><pub-id pub-id-type="pmid">15240603</pub-id><pub-id pub-id-type="doi">10.1210/jc.2003-031706</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hansen</surname><given-names>PS</given-names></name><name><surname>Brix</surname><given-names>TH</given-names></name><name><surname>Sorensen</surname><given-names>TI</given-names></name><name><surname>Kyvik</surname><given-names>KO</given-names></name><name><surname>Hegedus</surname><given-names>L</given-names></name></person-group><article-title>Major genetic influence on the regulation of the pituitary-thyroid axis: a study of healthy Danish twins</article-title><source>J Clin Endocrinol Metab</source><year>2004</year><volume>89</volume><fpage>1181</fpage><lpage>1187</lpage><pub-id pub-id-type="pmid">15001606</pub-id><pub-id pub-id-type="doi">10.1210/jc.2003-031641</pub-id></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meikle</surname><given-names>AW</given-names></name><name><surname>Stringham</surname><given-names>JD</given-names></name><name><surname>Woodward</surname><given-names>MG</given-names></name><name><surname>Nelson</surname><given-names>JC</given-names></name></person-group><article-title>Hereditary and environmental influences on the variation of thyroid hormones in normal male twins</article-title><source>J Clin Endocrinol Metab</source><year>1988</year><volume>66</volume><fpage>588</fpage><lpage>592</lpage><pub-id pub-id-type="pmid">3350909</pub-id></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vaidya</surname><given-names>B</given-names></name><name><surname>Imrie</surname><given-names>H</given-names></name><name><surname>Perros</surname><given-names>P</given-names></name><name><surname>Young</surname><given-names>ET</given-names></name><name><surname>Kelly</surname><given-names>WF</given-names></name><name><surname>Carr</surname><given-names>D</given-names></name><name><surname>Large</surname><given-names>DM</given-names></name><name><surname>Toft</surname><given-names>AD</given-names></name><name><surname>Kendall-Taylor</surname><given-names>P</given-names></name><name><surname>Pearce</surname><given-names>SH</given-names></name></person-group><article-title>Evidence for a new Graves disease susceptibility locus at chromosome 18q21</article-title><source>Am J Hum Genet</source><year>2000</year><volume>66</volume><fpage>1710</fpage><lpage>1714</lpage><pub-id pub-id-type="pmid">10762555</pub-id><pub-id pub-id-type="doi">10.1086/302908</pub-id></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hadj</surname><given-names>KH</given-names></name><name><surname>Rebai</surname><given-names>A</given-names></name><name><surname>Kaffel</surname><given-names>N</given-names></name><name><surname>Abid</surname><given-names>M</given-names></name><name><surname>Ayadi</surname><given-names>H</given-names></name></person-group><article-title>Evidence for linkage and association between autoimmune thyroid diseases and the 18q12&#x02013;q21 region in a large Tunisian family</article-title><source>Int J Immunogenet</source><year>2006</year><volume>33</volume><fpage>25</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">16426239</pub-id><pub-id pub-id-type="doi">10.1111/j.1744-313X.2005.00554.x</pub-id></citation></ref><ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cupples</surname><given-names>LA</given-names></name><name><surname>Arruda</surname><given-names>H</given-names></name><name><surname>Benjamin</surname><given-names>EJ</given-names></name><name><surname>D'Agostino</surname><given-names>RB</given-names><suffix>Sr</suffix></name><name><surname>Demissie</surname><given-names>S</given-names></name><name><surname>DeStefano</surname><given-names>AL</given-names></name><name><surname>Dupuis</surname><given-names>J</given-names></name><name><surname>Falls</surname><given-names>K</given-names></name><name><surname>Fox</surname><given-names>CS</given-names></name><name><surname>Gottlieb</surname><given-names>DJ</given-names></name><name><surname>Govindaraju</surname><given-names>DR</given-names></name><name><surname>Guo</surname><given-names>CY</given-names></name><name><surname>Hwang</surname><given-names>SJ</given-names></name><name><surname>Kathiresan</surname><given-names>S</given-names></name><name><surname>Kiel</surname><given-names>DP</given-names></name><name><surname>Larson</surname><given-names>MG</given-names></name><name><surname>Laramie</surname><given-names>JM</given-names></name><name><surname>Levy</surname><given-names>D</given-names></name><name><surname>Lunetta</surname><given-names>KL</given-names></name><name><surname>Mailman</surname><given-names>MD</given-names></name><name><surname>Manning</surname><given-names>AK</given-names></name><name><surname>Meigs</surname><given-names>JB</given-names></name><name><surname>Murabito</surname><given-names>JM</given-names></name><name><surname>Newton-Cheh</surname><given-names>C</given-names></name><name><surname>O'Connor</surname><given-names>GT</given-names></name><name><surname>O'Donnell</surname><given-names>CJ</given-names></name><name><surname>Pandey</surname><given-names>MA</given-names></name><name><surname>Qiong</surname><given-names>Y</given-names></name><name><surname>Seshadri</surname><given-names>S</given-names></name><name><surname>Vasan</surname><given-names>RS</given-names></name><name><surname>Wang</surname><given-names>ZY</given-names></name><name><surname>Wolf</surname><given-names>PA</given-names></name><name><surname>Atwood</surname><given-names>LD</given-names></name></person-group><article-title>The Framingham Heart Study 100K SNP genome-wide association study resource: Overview of 17 phenotype working group reports</article-title><source>BMC Med Genet</source><year>2007</year><volume>8</volume><fpage>S1</fpage></citation></ref><ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Levey</surname><given-names>AS</given-names></name><name><surname>Bosch</surname><given-names>JP</given-names></name><name><surname>Lewis</surname><given-names>JB</given-names></name><name><surname>Greene</surname><given-names>T</given-names></name><name><surname>Rogers</surname><given-names>N</given-names></name><name><surname>Roth</surname><given-names>D</given-names></name></person-group><article-title>A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group</article-title><source>Ann Intern Med</source><year>1999</year><volume>130</volume><fpage>461</fpage><lpage>470</lpage><pub-id pub-id-type="pmid">10075613</pub-id></citation></ref><ref id="B39"><citation citation-type="journal"><article-title>K/DOQI clinical practice guidelines for chronic kidney disease : evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative</article-title><source>Am J Kidney Dis</source><year>2002</year><volume>39</volume><fpage>S1</fpage><lpage>246</lpage><pub-id pub-id-type="pmid">11904577</pub-id><pub-id pub-id-type="doi">10.1053/ajkd.2002.32799</pub-id></citation></ref><ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nathan</surname><given-names>DM</given-names></name><name><surname>Rosenbaum</surname><given-names>C</given-names></name><name><surname>Protasowicki</surname><given-names>VD</given-names></name></person-group><article-title>Single-void urine samples can be used to estimate quantitative microalbuminuria</article-title><source>Diabetes Care</source><year>1987</year><volume>10</volume><fpage>414</fpage><lpage>418</lpage><pub-id pub-id-type="pmid">3622198</pub-id><pub-id pub-id-type="doi">10.2337/diacare.10.4.414</pub-id></citation></ref><ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bakker</surname><given-names>AJ</given-names></name></person-group><article-title>Detection of microalbuminuria. Receiver operating characteristic curve analysis favors albumin-to-creatinine ratio over albumin concentration</article-title><source>Diabetes Care</source><year>1999</year><volume>22</volume><fpage>307</fpage><lpage>313</lpage><pub-id pub-id-type="pmid">10333950</pub-id><pub-id pub-id-type="doi">10.2337/diacare.22.2.307</pub-id></citation></ref><ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Parikh</surname><given-names>NI</given-names></name><name><surname>Hwang</surname><given-names>SJ</given-names></name><name><surname>Larson</surname><given-names>MG</given-names></name><name><surname>Meigs</surname><given-names>JB</given-names></name><name><surname>Levy</surname><given-names>D</given-names></name><name><surname>Fox</surname><given-names>CS</given-names></name></person-group><article-title>Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control</article-title><source>Arch Intern Med</source><year>2006</year><volume>166</volume><fpage>1884</fpage><lpage>1891</lpage><pub-id pub-id-type="pmid">17000946</pub-id><pub-id pub-id-type="doi">10.1001/archinte.166.17.1884</pub-id></citation></ref><ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Amin</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Sawin</surname><given-names>CT</given-names></name><name><surname>Evans</surname><given-names>SR</given-names></name><name><surname>Hannan</surname><given-names>MT</given-names></name><name><surname>Kiel</surname><given-names>DP</given-names></name><name><surname>Wilson</surname><given-names>PW</given-names></name><name><surname>Felson</surname><given-names>DT</given-names></name></person-group><article-title>Association of hypogonadism and estradiol levels with bone mineral density in elderly men from the Framingham study</article-title><source>Ann Intern Med</source><year>2000</year><volume>133</volume><fpage>951</fpage><lpage>963</lpage><pub-id pub-id-type="pmid">11119396</pub-id></citation></ref><ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arnlov</surname><given-names>J</given-names></name><name><surname>Pencina</surname><given-names>MJ</given-names></name><name><surname>Amin</surname><given-names>S</given-names></name><name><surname>Nam</surname><given-names>BH</given-names></name><name><surname>Benjamin</surname><given-names>EJ</given-names></name><name><surname>Murabito</surname><given-names>JM</given-names></name><name><surname>Wang</surname><given-names>TJ</given-names></name><name><surname>Knapp</surname><given-names>PE</given-names></name><name><surname>D'Agostino</surname><given-names>RB</given-names><suffix>Sr</suffix></name><name><surname>Bhasin</surname><given-names>S</given-names></name><name><surname>Vasan</surname><given-names>RS</given-names></name></person-group><article-title>Endogenous sex hormones and cardiovascular disease incidence in men</article-title><source>Ann Intern Med</source><year>2006</year><volume>145</volume><fpage>176</fpage><lpage>184</lpage><pub-id pub-id-type="pmid">16880459</pub-id></citation></ref><ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Q</given-names></name><name><surname>Guo</surname><given-names>CY</given-names></name><name><surname>Cupples</surname><given-names>LA</given-names></name><name><surname>Levy</surname><given-names>D</given-names></name><name><surname>Wilson</surname><given-names>PW</given-names></name><name><surname>Fox</surname><given-names>CS</given-names></name></person-group><article-title>Genome-wide search for genes affecting serum uric acid levels: the Framingham Heart Study</article-title><source>Metabolism</source><year>2005</year><volume>54</volume><fpage>1435</fpage><lpage>1441</lpage><pub-id pub-id-type="pmid">16253630</pub-id><pub-id pub-id-type="doi">10.1016/j.metabol.2005.05.007</pub-id></citation></ref><ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Camp</surname><given-names>TM</given-names></name><name><surname>Smiley</surname><given-names>LM</given-names></name><name><surname>Hayden</surname><given-names>MR</given-names></name><name><surname>Tyagi</surname><given-names>SC</given-names></name></person-group><article-title>Mechanism of matrix accumulation and glomerulosclerosis in spontaneously hypertensive rats</article-title><source>J Hypertens</source><year>2003</year><volume>21</volume><fpage>1719</fpage><lpage>1727</lpage><pub-id pub-id-type="pmid">12923405</pub-id><pub-id pub-id-type="doi">10.1097/00004872-200309000-00022</pub-id></citation></ref><ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ginsberg</surname><given-names>J</given-names></name><name><surname>Labedz</surname><given-names>T</given-names></name><name><surname>Brindley</surname><given-names>DN</given-names></name></person-group><article-title>Phosphorylation of Heat Shock Protein-90 by TSH in FRTL-5 Thyroid Cells</article-title><source>Thyroid</source><year>2006</year><volume>16</volume><fpage>737</fpage><lpage>742</lpage><pub-id pub-id-type="pmid">16910874</pub-id><pub-id pub-id-type="doi">10.1089/thy.2006.16.737</pub-id></citation></ref><ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kanaya</surname><given-names>AM</given-names></name><name><surname>Harris</surname><given-names>F</given-names></name><name><surname>Volpato</surname><given-names>S</given-names></name><name><surname>Perez-Stable</surname><given-names>EJ</given-names></name><name><surname>Harris</surname><given-names>T</given-names></name><name><surname>Bauer</surname><given-names>DC</given-names></name></person-group><article-title>Association between thyroid dysfunction and total cholesterol level in an older biracial population: the health, aging and body composition study</article-title><source>Arch Intern Med</source><year>2002</year><volume>162</volume><fpage>773</fpage><lpage>779</lpage><pub-id pub-id-type="pmid">11926850</pub-id><pub-id pub-id-type="doi">10.1001/archinte.162.7.773</pub-id></citation></ref><ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eriksson</surname><given-names>P</given-names></name><name><surname>Deguchi</surname><given-names>H</given-names></name><name><surname>Samnegard</surname><given-names>A</given-names></name><name><surname>Lundman</surname><given-names>P</given-names></name><name><surname>Boquist</surname><given-names>S</given-names></name><name><surname>Tornvall</surname><given-names>P</given-names></name><name><surname>Ericsson</surname><given-names>CG</given-names></name><name><surname>Bergstrand</surname><given-names>L</given-names></name><name><surname>Hansson</surname><given-names>LO</given-names></name><name><surname>Ye</surname><given-names>S</given-names></name><name><surname>Hamsten</surname><given-names>A</given-names></name></person-group><article-title>Human evidence that the cystatin C gene is implicated in focal progression of coronary artery disease</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2004</year><volume>24</volume><fpage>551</fpage><lpage>557</lpage><pub-id pub-id-type="pmid">14726415</pub-id><pub-id pub-id-type="doi">10.1161/01.ATV.0000117180.57731.36</pub-id></citation></ref><ref id="B50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hsu</surname><given-names>CC</given-names></name><name><surname>Kao</surname><given-names>WH</given-names></name><name><surname>Coresh</surname><given-names>J</given-names></name><name><surname>Pankow</surname><given-names>JS</given-names></name><name><surname>Marsh-Manzi</surname><given-names>J</given-names></name><name><surname>Boerwinkle</surname><given-names>E</given-names></name><name><surname>Bray</surname><given-names>MS</given-names></name></person-group><article-title>Apolipoprotein E and progression of chronic kidney disease</article-title><source>JAMA</source><year>2005</year><volume>293</volume><fpage>2892</fpage><lpage>2899</lpage><pub-id pub-id-type="pmid">15956634</pub-id><pub-id pub-id-type="doi">10.1001/jama.293.23.2892</pub-id></citation></ref><ref id="B51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rule</surname><given-names>AD</given-names></name><name><surname>Larson</surname><given-names>TS</given-names></name><name><surname>Bergstralh</surname><given-names>EJ</given-names></name><name><surname>Slezak</surname><given-names>JM</given-names></name><name><surname>Jacobsen</surname><given-names>SJ</given-names></name><name><surname>Cosio</surname><given-names>FG</given-names></name></person-group><article-title>Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease</article-title><source>Ann Intern Med</source><year>2004</year><volume>141</volume><fpage>929</fpage><lpage>937</lpage><pub-id pub-id-type="pmid">15611490</pub-id></citation></ref><ref id="B52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rule</surname><given-names>AD</given-names></name><name><surname>Bergstralh</surname><given-names>EJ</given-names></name><name><surname>Slezak</surname><given-names>JM</given-names></name><name><surname>Bergert</surname><given-names>J</given-names></name><name><surname>Larson</surname><given-names>TS</given-names></name></person-group><article-title>Glomerular filtration rate estimated by cystatin C among different clinical presentations</article-title><source>Kidney Int</source><year>2006</year><volume>69</volume><fpage>399</fpage><lpage>405</lpage><pub-id pub-id-type="pmid">16408133</pub-id><pub-id pub-id-type="doi">10.1038/sj.ki.5000073</pub-id></citation></ref><ref id="B53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hoek</surname><given-names>FJ</given-names></name><name><surname>Kemperman</surname><given-names>FA</given-names></name><name><surname>Krediet</surname><given-names>RT</given-names></name></person-group><article-title>A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate</article-title><source>Nephrol Dial Transplant</source><year>2003</year><volume>18</volume><fpage>2024</fpage><lpage>2031</lpage><pub-id pub-id-type="pmid">13679476</pub-id><pub-id pub-id-type="doi">10.1093/ndt/gfg349</pub-id></citation></ref><ref id="B54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grubb</surname><given-names>A</given-names></name><name><surname>Bjork</surname><given-names>J</given-names></name><name><surname>Lindstrom</surname><given-names>V</given-names></name><name><surname>Sterner</surname><given-names>G</given-names></name><name><surname>Bondesson</surname><given-names>P</given-names></name><name><surname>Nyman</surname><given-names>U</given-names></name></person-group><article-title>A cystatin C-based formula without anthropometric variables estimates glomerular filtration rate better than creatinine clearance using the Cockcroft-Gault formula</article-title><source>Scand J Clin Lab Invest</source><year>2005</year><volume>65</volume><fpage>153</fpage><lpage>162</lpage><pub-id pub-id-type="pmid">16025838</pub-id><pub-id pub-id-type="doi">10.1080/00365510510013596</pub-id></citation></ref><ref id="B55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shlipak</surname><given-names>MG</given-names></name><name><surname>Sarnak</surname><given-names>MJ</given-names></name><name><surname>Katz</surname><given-names>R</given-names></name><name><surname>Fried</surname><given-names>LF</given-names></name><name><surname>Seliger</surname><given-names>SL</given-names></name><name><surname>Newman</surname><given-names>AB</given-names></name><name><surname>Siscovick</surname><given-names>DS</given-names></name><name><surname>Stehman-Breen</surname><given-names>C</given-names></name></person-group><article-title>Cystatin C and the risk of death and cardiovascular events among elderly persons</article-title><source>N Engl J Med</source><year>2005</year><volume>352</volume><fpage>2049</fpage><lpage>2060</lpage><pub-id pub-id-type="pmid">15901858</pub-id><pub-id pub-id-type="doi">10.1056/NEJMoa043161</pub-id></citation></ref><ref id="B56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shlipak</surname><given-names>MG</given-names></name><name><surname>Wassel Fyr</surname><given-names>CL</given-names></name><name><surname>Chertow</surname><given-names>GM</given-names></name><name><surname>Harris</surname><given-names>TB</given-names></name><name><surname>Kritchevsky</surname><given-names>SB</given-names></name><name><surname>Tylavsky</surname><given-names>FA</given-names></name><name><surname>Satterfield</surname><given-names>S</given-names></name><name><surname>Cummings</surname><given-names>SR</given-names></name><name><surname>Newman</surname><given-names>AB</given-names></name><name><surname>Fried</surname><given-names>LF</given-names></name></person-group><article-title>Cystatin C and mortality risk in the elderly: the health, aging, and body composition study</article-title><source>J Am Soc Nephrol</source><year>2006</year><volume>17</volume><fpage>254</fpage><lpage>261</lpage><pub-id pub-id-type="pmid">16267155</pub-id><pub-id pub-id-type="doi">10.1681/ASN.2005050545</pub-id></citation></ref><ref id="B57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fried</surname><given-names>LF</given-names></name><name><surname>Katz</surname><given-names>R</given-names></name><name><surname>Sarnak</surname><given-names>MJ</given-names></name><name><surname>Shlipak</surname><given-names>MG</given-names></name><name><surname>Chaves</surname><given-names>PH</given-names></name><name><surname>Jenny</surname><given-names>NS</given-names></name><name><surname>Stehman-Breen</surname><given-names>C</given-names></name><name><surname>Gillen</surname><given-names>D</given-names></name><name><surname>Bleyer</surname><given-names>AJ</given-names></name><name><surname>Hirsch</surname><given-names>C</given-names></name><name><surname>Siscovick</surname><given-names>D</given-names></name><name><surname>Newman</surname><given-names>AB</given-names></name></person-group><article-title>Kidney function as a predictor of noncardiovascular mortality</article-title><source>J Am Soc Nephrol</source><year>2005</year><volume>16</volume><fpage>3728</fpage><lpage>3735</lpage><pub-id pub-id-type="pmid">16251239</pub-id><pub-id pub-id-type="doi">10.1681/ASN.2005040384</pub-id></citation></ref><ref id="B58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>O'Hare</surname><given-names>AM</given-names></name><name><surname>Newman</surname><given-names>AB</given-names></name><name><surname>Katz</surname><given-names>R</given-names></name><name><surname>Fried</surname><given-names>LF</given-names></name><name><surname>Stehman-Breen</surname><given-names>CO</given-names></name><name><surname>Seliger</surname><given-names>SL</given-names></name><name><surname>Siscovick</surname><given-names>DS</given-names></name><name><surname>Shlipak</surname><given-names>MG</given-names></name></person-group><article-title>Cystatin C and incident peripheral arterial disease events in the elderly: results from the Cardiovascular Health Study</article-title><source>Arch Intern Med</source><year>2005</year><volume>165</volume><fpage>2666</fpage><lpage>2670</lpage><pub-id pub-id-type="pmid">16344426</pub-id><pub-id pub-id-type="doi">10.1001/archinte.165.22.2666</pub-id></citation></ref><ref id="B59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shlipak</surname><given-names>MG</given-names></name><name><surname>Katz</surname><given-names>R</given-names></name><name><surname>Fried</surname><given-names>LF</given-names></name><name><surname>Jenny</surname><given-names>NS</given-names></name><name><surname>Stehman-Breen</surname><given-names>CO</given-names></name><name><surname>Newman</surname><given-names>AB</given-names></name><name><surname>Siscovick</surname><given-names>D</given-names></name><name><surname>Psaty</surname><given-names>BM</given-names></name><name><surname>Sarnak</surname><given-names>MJ</given-names></name></person-group><article-title>Cystatin-C and mortality in elderly persons with heart failure</article-title><source>J Am Coll Cardiol</source><year>2005</year><volume>45</volume><fpage>268</fpage><lpage>271</lpage><pub-id pub-id-type="pmid">15653026</pub-id><pub-id pub-id-type="doi">10.1016/j.jacc.2004.09.061</pub-id></citation></ref></ref-list></back></article> 